Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40759040	s-c-pep-a	nmol/l (nmol/l)	2002	2482	0.00%
40759040	p-c-pepta	nmol/l (nmol/l)	1073	1442	1.25%
40759040	s-c-pep-a	— (—)	320	417	100.00%	Distribution not available
40759040	p-c-pepta	— (—)	118	134	100.00%	Distribution not available
40759040	s-c-peptidi1haterianjälkeen	nmol/l (nmol/l)	95	99	0.00%
40759040	s-c-pepaj	nmol/l (nmol/l)	54	64	0.00%
40759040	s-c-peptidi1haterianjäkeen	nmol/l (nmol/l)	36	39	0.00%
40759040	c-pepta	nmol/l (nmol/l)	10	13	0.00%	Distribution not available
40759040	s-c-peptidi1haterianjälkeen	— (—)	5	5	100.00%	Distribution not available	Distribution not available
40759040	s-c-pepaj	— (—)	5	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Cardiac arrhythmias

374

176

14.17

316.03

1.4

1.8

1.63

1.53

nmol/l

0.46

343

160

Type 2 diabetes, definitions combined

1947

234

51.35

307.65

1.3

1.8

1.57

1.55

nmol/l

0.13

1797

214

Type 2 diabetes, wide definition

1832

291

42.73

307.65

1.3

1.6

1.47

1.20

nmol/l

4.12

1664

258

Statin medication

790

728

6.17

307.65

1.3

1.4

1.49

1.33

nmol/l

2.42

704

671

Diabetes medication

2405

363

41.79

307.65

1.3

1.8

1.42

1.51

nmol/l

0.85

2162

337

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

973

194

55.07

307.65

1.3

1.6

1.67

1.24

nmol/l

5.21

909

169

Type 1 diabetes

583

62.75

307.65

1.4

1.9

0.81

1.66

nmol/l

7.91

474

Dipeptidyl peptidase 4 (DPP-4) inhibitors

311

43.83

307.65

1.3

1.6

1.36

1.44

nmol/l

0.19

288

Diabetes, varying definitions

2330

294

49.09

307.65

1.3

1.8

1.42

1.49

nmol/l

0.47

2106

268

Insulin, combination of fast acting with intermediate-acting or long-acting

2277

830

27.09

307.65

1.3

1.24

1.75

nmol/l

29.08

2043

760

Sub-endpoint used in defining T1D endpoints

611

812

7.66

307.65

1.4

1.3

0.81

1.55

nmol/l

44.01

503

744

Biguanides

2126

550

24.70

307.65

1.3

1.6

1.48

1.24

nmol/l

5.18

1945

484

Insulin medication

2276

271

77.08

307.65

1.3

1.6

1.24

1.53

nmol/l

4.05

2042

250

Combinations of oral blood glucose lowering drugs

741

210

37.48

307.65

1.3

1.5

1.44

1.25

nmol/l

1.48

679

184

Type 1 diabetes, wide definition, subgroup 1

442

65.79

307.65

1.4

1.9

0.78

1.78

nmol/l

7.14

347

Type 2 diabetes

2214

249

54.75

307.65

1.3

1.8

1.47

1.54

nmol/l

0.48

2005

228

Insulin, fast-acting

1306

483

29.08

307.65

1.4

1.3

1.02

1.67

nmol/l

27.09

1140

437

Endocrine, nutritional and metabolic diseases

1012

166

31.54

307.65

1.4

1.3

1.42

1.56

nmol/l

0.78

909

150

Glucagon-like peptide-1 (GLP-1) analogues

1541

323

41.58

307.65

1.3

1.5

1.52

1.24

nmol/l

4.40

1413

281

Type 2 diabetes, strict (exclude DM1)

1951

281

42.86

307.65

1.3

1.7

1.57

1.45

nmol/l

0.99

1801

258

Type 2 diabetes, definitions combined, including avohilmo

1912

249

46.96

307.65

1.3

1.8

1.58

1.35

nmol/l

3.08

1764

231

Other blood glucose lowering drugs, excl. Insulins

456

50.15

307.65

1.3

1.6

1.43

1.41

nmol/l

0.05

404

Diabetes mellitus

2357

275

53.04

307.65

1.3

1.8

1.42

1.55

nmol/l

1.12

2129

252

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2428

245

63.07

307.65

1.3

1.7

1.40

1.55

nmol/l

1.22

2180

224

Type 1 diabetes, wide definition

457

57.96

307.65

1.4

1.8

0.78

1.74

nmol/l

7.74

361

Diabetes, insulin treatment (Kela reimbursement)

2495

388

40.94

307.65

1.3

1.6

1.40

1.58

nmol/l

2.24

2244

358

Other (not insulin) diabetes medications

2203

335

41.15

307.65

1.3

1.7

1.50

nmol/l

0.00

2003

312

Sulfonylureas

797

163

40.82

307.65

1.2

1.4

1.20

1.29

nmol/l

0.38

725

139

Insulin, fast-acting or short human

1310

828

16.95

307.65

1.4

1.3

1.02

1.61

nmol/l

37.23

1144

756

Insulin, intermediate and long-acting

2086

774

28.48

307.65

1.3

1.22

1.75

nmol/l

29.18

1856

709

Any reimbursement code in KELA

517

225

11.64

307.65

1.4

1.6

1.36

1.58

nmol/l

1.91

466

210

Obesity

764

1898

4.06

267.72

1.5

1.3

1.72

1.35

nmol/l

12.41

707

1701

Obesity and other hyperalimentation

766

1906

4.05

267.51

1.5

1.3

1.72

1.35

nmol/l

12.08

709

1709

Chronic pancreatitis

327

391

8.88

254.69

1.4

1.3

0.91

1.52

nmol/l

15.18

291

350

Other nutritional deficiencies

769

2006

3.81

245.92

1.5

1.3

1.71

1.35

nmol/l

11.74

710

1796

Hypertension, essential

828

1187

4.03

238.94

1.4

1.61

1.30

nmol/l

8.87

737

1066

Hypertensive diseases

834

1217

3.93

232.08

1.4

1.61

1.30

nmol/l

9.09

739

1094

Hypertension

834

1217

3.93

232.00

1.4

1.61

1.30

nmol/l

9.09

739

1094

Hypertensive diseases (excluding secondary)

616

790

4.60

209.21

1.4

1.59

1.26

nmol/l

7.76

548

715

Obesity due to excess calories

564

1388

4.14

203.73

1.5

1.3

1.76

1.36

nmol/l

9.99

518

1235

Obesity, other/unspecified

437

941

4.74

187.65

1.6

1.3

1.72

1.42

nmol/l

4.92

409

838

Hypothyroidism, levothyroxine purchases

200

19.05

172.49

1.3

1.52

1.72

nmol/l

0.65

174

Hypothyroidism and >3 levothyroxin purchases

200

19.05

172.49

1.3

1.52

1.72

nmol/l

0.65

174

Hypothyroidism (congenital or acquired)

200

19.03

172.27

1.3

1.52

1.72

nmol/l

0.64

172

Acute pancreatitis

314

572

5.66

163.97

1.4

1.3

1.09

1.50

nmol/l

7.91

285

511

Metabolic disorders

917

2039

2.82

160.47

1.3

1.43

nmol/l

0.05

828

1841

Disorders of gallbladder, biliary tract and pancreas

934

2241

2.71

153.71

1.3

1.32

1.48

nmol/l

4.12

845

2026

Alcohol-induced chronic pancreatitis

186

207

9.64

153.69

1.4

1.2

0.86

1.47

nmol/l

8.86

167

188

Depression medications

207

16.16

152.18

1.5

1.3

1.52

1.70

nmol/l

0.55

189

Neurological diseases, wide definition

206

14.68

145.70

1.4

1.55

1.68

nmol/l

0.33

185

Acute pancreatitis (for exclusion)

314

641

5.04

144.30

1.4

1.3

1.09

1.50

nmol/l

8.20

285

575

Disorders of lipoprotein metabolism and other lipidaemias

792

1797

2.80

137.23

1.3

1.48

1.43

nmol/l

0.57

707

1621

Diabetes mellitus in pregnancy

312

379

5.42

132.58

1.5

1.4

1.49

1.43

nmol/l

0.30

283

341

Autoimmune diseases excluding thyroid diseases

929

2028

2.56

131.47

1.4

1.3

1.21

1.50

nmol/l

11.64

814

1881

Antihypertensive medication - note that there are other indications

479

698

3.79

126.21

1.3

1.4

1.47

1.27

nmol/l

2.92

429

645

Autoimmune diseases excluding thyroid diseases, strict definition

896

1977

2.55

125.30

1.4

1.3

1.19

1.50

nmol/l

12.49

781

1831

Gestational diabetes (for exclusion)

325

523

4.46

115.79

1.5

1.4

1.45

1.49

nmol/l

0.23

302

467

Tramadol

705

1740

2.63

109.55

1.4

1.3

1.51

1.38

nmol/l

1.99

640

1569

Autoimmune diseases

935

2038

2.36

108.99

1.4

1.3

1.29

1.50

nmol/l

6.21

822

1891

Elevated blood glucose level

165

240

7.19

108.41

1.5

1.4

1.18

1.47

nmol/l

2.06

143

215

Other disorders of glucose regulation and pancreatic internal secretion

160

225

7.40

108.29

2.6

1.3

1.02

1.38

nmol/l

3.07

139

203

Infections, IBD-co-morbidities

100

21.65

107.62

1.8

1.4

1.30

1.60

nmol/l

0.49

Heart failure and antihypertensive medication

221

243

6.09

106.14

1.3

1.4

1.73

1.19

nmol/l

6.66

196

220

Heart failure, not strict

674

1850

2.54

99.47

1.3

1.61

1.38

nmol/l

4.70

588

1688

Cardiovascular diseases (excluding rheumatic etc)

515

997

3.01

98.77

1.4

1.54

1.28

nmol/l

4.83

462

908

Diseases of arteries, arterioles and capillaries (FINNGEN)

247

354

4.95

98.74

1.4

1.46

1.19

nmol/l

2.66

219

323

Persons encountering health services for other counselling and medical advice, not elsewhere classified

918

2367

2.23

97.09

1.4

1.3

1.47

1.42

nmol/l

0.54

831

2145

Hypoglycaemia, other or unspecified

133

174

7.98

95.99

2.8

1.3

1.06

1.42

nmol/l

2.35

115

156

Insulin, fast-acting (human)

134

179

7.61

94.42

1.4

0.83

1.77

nmol/l

13.02

164

Other retinal disorders

545

1652

2.68

93.20

1.3

1.15

1.46

nmol/l

9.67

443

1519

Other diseases of pancreas

143

211

7.09

92.78

1.3

1.07

1.51

nmol/l

3.64

128

187

Alcohol use disorder, Swedish definition

531

1903

2.62

89.78

1.4

1.3

1.32

1.44

nmol/l

1.53

479

1717

Pure hypercholesterolaemia

617

1660

2.52

89.12

1.3

1.46

1.43

nmol/l

0.22

556

1496

Continuous positive airway pressure

17.38

88.85

1.2

1.5

1.34

1.54

nmol/l

0.46

Used for control exclusion in common control thyroid runs

836

1929

2.21

84.26

1.3

1.31

1.51

nmol/l

4.81

737

1787

Persons encountering health services in other circumstances, wide

949

2370

2.09

83.98

1.4

1.3

1.42

1.43

nmol/l

0.02

858

2148

556

2046

2.46

81.89

1.3

1.31

1.44

nmol/l

1.96

503

1851

534

1989

2.49

81.30

1.4

1.3

1.30

1.44

nmol/l

2.14

483

1799

General examination and investigation of persons without complaint and reported diagnosis

583

1225

2.55

81.20

1.3

1.62

1.41

nmol/l

3.75

536

1112

Peripheral artery disease

399

1146

2.84

76.12

1.3

1.2

1.39

1.40

nmol/l

0.04

347

1032

Renal tubulo-interstitial diseases

672

2358

2.20

74.59

1.3

1.58

1.41

nmol/l

3.17

606

2129

Ischemic heart diseases

639

1794

2.25

71.10

1.3

1.57

1.37

nmol/l

3.84

573

1615

Other bacterial diseases

735

2456

2.08

69.44

1.4

1.3

1.46

1.42

nmol/l

0.46

664

2218

Coronary atherosclerosis

557

1544

2.35

68.81

1.3

1.53

1.37

nmol/l

2.54

497

1395

Cardiovascular diseases

440

906

2.66

67.19

1.4

1.52

1.27

nmol/l

3.96

390

830

Diseases of liver

322

1141

2.86

65.69

1.3

1.50

1.42

nmol/l

0.54

287

1020

Disorders of choroid and retina

620

2108

2.16

64.86

1.3

1.20

1.48

nmol/l

8.27

512

1936

Glomerular disorders in diseases classified elsewhere

158

368

4.41

62.04

1.4

1.3

1.38

1.47

nmol/l

0.39

131

325

Renal failure

357

1251

2.64

61.26

1.3

1.64

1.38

nmol/l

2.96

321

1126

Ischaemic heart disease, wide definition

610

1796

2.14

60.48

1.3

1.54

1.39

nmol/l

2.34

544

1621

Sleep apnoea

701

2388

2.00

59.57

1.3

1.71

1.35

nmol/l

11.04

646

2150

Other heart diseases

330

783

2.80

58.89

1.4

1.59

1.24

nmol/l

5.45

299

709

Nerve, nerve root and plexus disorders

786

2580

1.92

58.59

1.4

1.3

1.49

1.42

nmol/l

1.02

711

2330

Obesity related asthma

306

1124

2.76

58.38

1.4

1.3

1.72

1.42

nmol/l

3.94

287

1007

Hypertensive Heart Disease

175

359

4.03

58.27

1.3

1.74

1.23

nmol/l

4.95

157

322

Opioids

710

1862

2.01

57.41

1.4

1.3

1.51

1.39

nmol/l

1.72

638

1683

Codeine

679

1845

2.03

57.13

1.4

1.3

1.47

1.39

nmol/l

1.01

610

1666

Sleep disorders (combined)

729

2471

1.94

56.58

1.3

1.68

1.35

nmol/l

10.54

671

2226

Parasetamol

599

1437

2.14

56.25

1.4

1.3

1.49

1.32

nmol/l

2.81

534

1303

Alcohol-induced acute pancreatitis

122

7.29

55.59

1.4

1.2

0.78

1.49

nmol/l

6.38

110

Explicit Sepsis

331

1240

2.58

55.24

1.3

1.55

1.39

nmol/l

1.48

295

1122

Hypertensive heart and/or renal disease

187

392

3.74

55.22

1.4

1.3

1.71

1.23

nmol/l

4.92

167

353

Substance abuse, excluding more controls

451

1763

2.26

54.85

1.4

1.3

1.37

1.39

nmol/l

0.21

405

1583

Mood disorders, excluding more controls

697

2170

1.97

54.84

1.4

1.3

1.52

1.41

nmol/l

1.70

643

1954

Sleep apnoea, including avohilmo

716

2416

1.93

54.62

1.3

1.72

1.35

nmol/l

12.15

660

2174

Septicaemia

316

1174

2.61

54.03

1.3

1.53

1.38

nmol/l

1.36

284

1064

Charcot foot

25.25

53.39

1.3

1.1

0.88

1.20

nmol/l

0.90

Other septicaemia

284

1033

2.73

52.99

1.3

1.2

1.51

1.39

nmol/l

1.01

259

932

STROKE

336

909

2.58

52.08

1.3

1.56

1.47

nmol/l

0.66

293

823

Other maternal disorders predominantly related to pregnancy

353

887

2.52

50.71

1.5

1.4

1.50

nmol/l

0.02

327

795

Ulcer of lower limb, not elsewhere classified

152

404

3.84

49.87

1.4

1.3

1.30

1.46

nmol/l

0.81

124

356

Codeine or tramadol medication

814

2492

1.82

49.64

1.4

1.3

1.49

1.40

nmol/l

1.10

732

2257

Certain infectious and parasitic diseases

722

1915

1.90

48.95

1.4

1.3

1.47

1.41

nmol/l

0.60

641

1755

Infections of the skin and subcutaneous tissue

443

2077

2.14

48.52

1.4

1.3

1.39

1.42

nmol/l

0.25

403

1872

Mood disorders

734

2637

1.84

48.18

1.4

1.3

1.52

1.40

nmol/l

2.09

675

2372

Mood [affective] disorders

733

2637

1.84

48.14

1.4

1.3

1.52

1.40

nmol/l

2.09

675

2371

Other disorders of fluid, electrolyte and acid-base balance

226

758

2.91

47.44

1.4

1.3

1.34

1.43

nmol/l

0.55

202

681

Examination and observation for other reasons

441

1220

2.21

47.21

1.3

1.41

nmol/l

0.02

396

1107

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

114

256

4.58

47.03

1.4

1.2

1.15

1.50

nmol/l

2.81

100

227

Abdominal and pelvic pain

734

1995

1.86

46.85

1.4

1.3

1.38

1.42

nmol/l

0.45

669

1799

Glomerular diseases

186

587

3.22

46.81

1.4

1.3

1.43

1.48

nmol/l

0.19

156

523

Cholelithiasis, broad definition with cholecystitis

574

2022

1.96

45.94

1.3

1.48

nmol/l

0.03

518

1831

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

678

2648

1.84

45.91

1.4

1.3

1.47

1.43

nmol/l

0.36

610

2395

Cholelithiasis

556

1990

1.97

45.65

1.3

1.50

1.48

nmol/l

0.14

504

1802

Other diseases of liver

172

529

3.30

45.16

1.3

1.65

1.46

nmol/l

1.23

148

475

Depression

673

2531

1.84

44.87

1.4

1.3

1.52

1.40

nmol/l

1.93

617

2277

Personality disorders, excluding more controls

211

739

2.88

44.14

1.4

1.3

1.62

1.43

nmol/l

1.67

198

662

Kidney transplant status

137

5.97

43.83

1.5

1.4

1.42

1.40

nmol/l

0.05

126

Transplanted organ and tissue status

119

292

4.17

43.73

1.4

1.3

1.42

1.47

nmol/l

0.19

104

258

Pain in throat and chest

604

1949

1.90

43.58

1.4

1.3

1.50

1.37

nmol/l

2.00

548

1763

Hard cardiovascular diseases

571

1909

1.93

43.42

1.2

1.3

1.60

1.38

nmol/l

4.03

511

1718

Diseases of arteries, arterioles and capillaries

481

1782

2.03

43.34

1.3

1.45

1.40

nmol/l

0.33

425

1613

Diseases of pulp and periapical tissues, including avohilmo

721

2076

1.81

42.97

1.4

1.3

1.44

1.42

nmol/l

0.22

652

1880

Asthma, excluding more controls

565

1544

1.96

42.92

1.4

1.3

1.55

1.35

nmol/l

3.88

522

1394

Substance abuse

451

2136

2.03

42.85

1.4

1.3

1.37

1.42

nmol/l

0.48

405

1937

Atherosclerosis, excluding cerebral and coronary sclerosis

313

1057

2.39

42.67

1.3

1.2

1.39

1.40

nmol/l

0.05

276

950

Episodal and paroxysmal disorders

766

2220

1.78

42.61

1.3

1.60

1.33

nmol/l

7.47

696

2002

General symptoms and signs

775

2205

1.77

42.32

1.4

1.3

1.48

1.40

nmol/l

0.90

700

1986

Dental pulpitis 1

720

2083

1.80

42.29

1.4

1.3

1.44

1.42

nmol/l

0.18

651

1887

Nonalcoholic fatty liver disease

113

274

4.22

42.22

1.4

1.3

1.78

1.46

nmol/l

1.86

253

Angina pectoris

432

1395

2.11

42.11

1.3

1.55

1.35

nmol/l

2.76

394

1264

Chronic kidney disease

231

866

2.68

42.08

1.3

1.2

1.71

1.38

nmol/l

3.12

204

778

Cutaneous abscess, furuncle and carbuncle

219

804

2.76

42.01

1.4

1.3

1.40

1.47

nmol/l

0.39

199

718

Dental pulpitis 4

719

2084

1.80

41.95

1.4

1.3

1.44

1.42

nmol/l

0.18

650

1888

Abnormalities of breathing

629

2021

1.86

41.94

1.4

1.3

1.55

1.37

nmol/l

3.07

574

1832

Dialysis, with operation codes

142

407

3.56

41.78

1.3

1.51

1.41

nmol/l

0.36

119

359

Mental and behavioural disorders due to psychoactive substance use

460

2186

2.00

41.70

1.4

1.3

1.34

1.43

nmol/l

0.94

414

1982

Atrial fibrillation and flutter

217

490

2.91

41.49

1.3

1.4

1.55

1.24

nmol/l

2.91

197

444

Psychiatric diseases

757

2153

1.77

41.31

1.4

1.3

1.44

1.41

nmol/l

0.29

684

1942

Peripheral artery operations in Hilmo

127

342

3.78

40.89

1.3

1.2

1.25

1.41

nmol/l

0.89

109

295

L04AD Calcineurin inhibitors

123

325

3.87

40.82

1.4

1.3

1.42

1.47

nmol/l

0.16

109

294

Dental pulpitis 1, only avohilmo

737

2185

1.77

40.69

1.4

1.3

1.41

1.42

nmol/l

0.14

666

1980

Intestinal malabsorption

120

6.13

40.46

1.5

1.3

0.97

1.45

nmol/l

2.70

108

Symptoms and signs involving the digestive system and abdomen

710

1995

1.79

40.44

1.4

1.3

1.38

1.42

nmol/l

0.53

648

1799

Lower back pain or/and sciatica

703

2788

1.76

40.43

1.4

1.3

1.57

1.40

nmol/l

3.37

646

2514

Nausea and vomiting

196

680

2.86

40.34

1.5

1.2

1.36

1.46

nmol/l

0.56

173

602

Implicit Sepsis

505

2041

1.93

40.26

1.3

1.49

1.41

nmol/l

0.81

451

1845

Coronary revascularization (ANGIO or CABG)

348

1091

2.24

39.93

1.2

1.3

1.59

1.33

nmol/l

3.42

318

987

Cerebrovascular diseases (FINNGEN)

208

523

2.87

39.76

1.4

1.56

1.27

nmol/l

2.48

186

468

Amputation

109

269

4.14

39.73

1.3

1.33

1.41

nmol/l

0.33

235

Influenza and pneumonia

717

2717

1.74

39.67

1.4

1.3

1.49

1.41

nmol/l

0.97

656

2453

Major coronary heart disease event

508

1756

1.94

39.67

1.2

1.3

1.57

1.37

nmol/l

3.03

459

1587

Dental pulpitis 4, only avohilmo

731

2180

1.76

39.56

1.4

1.3

1.41

1.42

nmol/l

0.13

660

1976

Mental and behavioural disorders due to alcohol, excluding acute intoxication

359

1691

2.14

39.39

1.4

1.3

1.38

1.41

nmol/l

0.22

320

1524

Condition for Implicit Sepsis (Organ dysfunction codes)

579

2293

1.84

39.39

1.3

1.47

1.42

nmol/l

0.45

517

2072

Atrial fibrillation and flutter with reimbursement

181

372

3.15

39.11

1.3

1.57

1.24

nmol/l

2.86

164

341

Fever of other and unknown origin

383

1713

2.09

38.97

1.3

1.56

1.40

nmol/l

1.85

354

1546

Alcohol use disorder, ICD-based

338

1564

2.18

38.95

1.3

1.39

1.41

nmol/l

0.10

300

1412

Nephropathy related operations

138

408

3.45

38.75

1.4

1.3

1.52

1.46

nmol/l

0.23

116

364

Bacterial Sepsis

316

1258

2.25

38.64

1.3

1.46

1.40

nmol/l

0.34

281

1142

Neurological diseases

594

1610

1.87

38.56

1.4

1.3

1.54

1.34

nmol/l

3.92

537

1455

Asthma

572

1642

1.88

38.47

1.4

1.3

1.56

1.36

nmol/l

3.50

528

1478

Other special examinations and investigations of persons without complaint or reported diagnosis

482

1225

2.00

38.30

1.3

1.47

1.41

nmol/l

0.61

436

1112

Diseases of the digestive system

320

1455

2.21

38.25

1.5

1.3

1.37

1.42

nmol/l

0.27

285

1308

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

609

2119

1.81

37.86

1.4

1.3

1.48

1.39

nmol/l

1.27

558

1917

609

2119

1.81

37.86

1.4

1.3

1.48

1.39

nmol/l

1.27

558

1917

Acute tubulo-interstitial nephritis

404

1777

2.03

37.85

1.3

1.53

1.41

nmol/l

1.25

363

1607

Asthma (mode)

565

1668

1.87

37.73

1.4

1.3

1.57

1.36

nmol/l

3.92

521

1499

Persons encountering health services for specific procedures and health care

733

2664

1.71

37.62

1.3

1.43

nmol/l

0.02

645

2435

Any mental disorder

759

2223

1.72

37.49

1.4

1.3

1.44

1.41

nmol/l

0.31

691

2004

Diseases of the skin and subcutaneous tissue

709

2049

1.74

36.91

1.4

1.3

1.45

1.42

nmol/l

0.25

631

1869

Erysipelas

394

1792

2.02

36.63

1.4

1.3

1.56

1.40

nmol/l

1.96

357

1618

Implicit bacterial Sepsis

275

1092

2.33

36.59

1.3

1.45

1.40

nmol/l

0.28

248

985

Other antidepressants

706

2133

1.73

36.52

1.4

1.3

1.53

1.37

nmol/l

3.09

646

1936

Abnormal findings on examination of blood, without diagnosis

355

1599

2.09

36.52

1.4

1.3

1.34

1.42

nmol/l

0.74

316

1450

Mental and behavioural disorders due to alcohol

391

1910

2.01

36.10

1.4

1.3

1.34

1.42

nmol/l

0.75

350

1725

Other diseases of biliary tract

208

4.42

35.82

1.3

1.22

1.51

nmol/l

1.15

185

Dorsalgia

685

2152

1.73

35.56

1.4

1.3

1.51

1.38

nmol/l

2.10

630

1936

Malaise and fatigue

334

1315

2.13

35.26

1.3

1.41

1.42

nmol/l

0.04

299

1183

Cholecystectomy

461

2169

1.89

35.19

1.4

1.3

1.50

1.43

nmol/l

0.65

422

1961

Dyspnoea

585

2554

1.76

34.77

1.4

1.3

1.58

1.41

nmol/l

3.08

534

2300

Pneumonias (Asthma/COPD co-morbidities)

668

2725

1.71

34.70

1.4

1.3

1.48

1.42

nmol/l

0.80

612

2457

Maternal care for other conditions predominantly related to pregnancy

126

371

3.38

34.61

1.7

1.4

1.35

1.49

nmol/l

0.72

114

331

All pneumoniae

670

2732

1.70

34.35

1.4

1.3

1.48

1.42

nmol/l

0.72

617

2463

Any gastric operation

544

1488

1.84

34.04

1.5

1.3

1.45

1.39

nmol/l

0.57

490

1360

GASTRO-related operations

544

1488

1.84

34.04

1.5

1.3

1.45

1.39

nmol/l

0.57

490

1360

Pneumonia, organism unspecified

608

2545

1.74

33.92

1.4

1.3

1.50

1.42

nmol/l

0.97

554

2291

Other soft tissue disorders, not elsewhere classified

604

2137

1.75

33.82

1.4

1.3

1.54

1.40

nmol/l

2.07

539

1944

ILD medications: prednisolone, methylprednisolone, prednisone

737

2508

1.67

33.75

1.4

1.3

1.58

1.37

nmol/l

5.06

670

2267

Poisoning by medicine

176

648

2.75

33.68

1.4

1.42

nmol/l

0.01

161

584

Coronary angioplasty

275

934

2.28

33.61

1.2

1.3

1.73

1.33

nmol/l

5.59

255

841

Poisoning by drugs, medicaments and biological substances

189

725

2.63

33.35

1.4

1.44

nmol/l

0.00

174

651

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

266

722

2.35

33.35

1.4

1.51

1.25

nmol/l

3.03

237

652

Anxiety disorders, excluding more controls

536

1982

1.80

33.35

1.4

1.3

1.55

1.41

nmol/l

1.95

493

1783

Dental caries

202

793

2.55

33.25

1.3

1.44

1.42

nmol/l

0.09

180

713

Secondary hypertension

120

5.45

33.17

1.4

1.3

1.66

1.12

nmol/l

2.71

108

Dentinal caries

182

684

2.67

33.09

1.3

1.41

1.42

nmol/l

0.06

161

617

Complications of procedures, not elsewhere classified

533

2614

1.77

32.90

1.5

1.3

1.50

1.42

nmol/l

0.87

474

2372

Asthma, hospital admission 2, infections

382

1935

1.95

32.84

1.4

1.3

1.63

1.37

nmol/l

4.14

357

1736

Asthma-related infections

382

1935

1.95

32.84

1.4

1.3

1.63

1.37

nmol/l

4.14

357

1736

Personality disorders

211

860

2.48

32.81

1.4

1.62

1.45

nmol/l

1.44

198

777

Hyperlipidaemia, other/unspecified

266

1132

2.24

32.67

1.3

1.2

1.52

1.38

nmol/l

1.22

237

1026

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

630

2525

1.70

32.47

1.4

1.3

1.46

1.43

nmol/l

0.28

560

2287

Hypothyroidism, strict autoimmune

448

1580

1.89

32.24

1.3

1.48

1.51

nmol/l

0.19

392

1462

Emergency coronary revascularization (for ACS)

380

1385

1.98

32.21

1.2

1.3

1.60

1.37

nmol/l

3.39

349

1246

Asthma (only as main-diagnosis), excluding more controls

479

1544

1.86

32.08

1.4

1.3

1.63

1.35

nmol/l

5.66

442

1394

Diseases of oesophagus, stomach and duodenum

705

2601

1.65

31.81

1.4

1.3

1.48

1.43

nmol/l

0.55

636

2357

300

1424

2.10

31.74

1.4

1.3

1.65

1.39

nmol/l

3.41

283

1281

Low back pain

491

2106

1.80

31.67

1.4

1.3

1.59

1.38

nmol/l

3.52

453

1894

Disorders of lens

478

1651

1.84

31.32

1.3

1.45

nmol/l

0.01

415

1502

Disorder of lipoprotein metabolism, unspecified

120

373

3.27

31.13

1.2

1.3

1.50

1.42

nmol/l

0.34

106

329

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

644

2722

1.67

31.06

1.4

1.3

1.48

1.42

nmol/l

0.72

587

2455

Sciatica+with lumbago

351

1709

1.96

30.43

1.4

1.3

1.60

1.38

nmol/l

2.92

328

1525

Disorders of adult personality and behaviour

214

910

2.37

30.34

1.4

1.67

1.43

nmol/l

2.16

199

821

Malignant neoplasm of pancreas

152

4.72

30.20

1.5

1.2

1.21

1.47

nmol/l

1.08

132

Complications of surgical and medical care, not elsewhere classified

631

2736

1.66

30.00

1.5

1.3

1.51

1.42

nmol/l

1.08

563

2480

Heart failure,strict

346

1264

1.99

29.56

1.2

1.3

1.65

1.34

nmol/l

4.87

308

1153

Symptoms and signs involving the circulatory and respiratory systems

669

2027

1.66

29.48

1.4

1.3

1.54

1.37

nmol/l

3.07

602

1837

ILD medications

740

2535

1.61

29.37

1.4

1.3

1.52

1.36

nmol/l

3.32

673

2292

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

270

1110

2.14

29.29

1.5

1.4

1.64

1.46

nmol/l

1.69

242

1004

Other and unspecified polyneuropathies, also in other diseases

157

588

2.70

29.20

1.4

1.2

1.23

1.50

nmol/l

2.30

137

524

Pregnancy hypertension

246

1008

2.21

29.18

1.5

1.4

1.64

1.47

nmol/l

1.50

221

916

Polyneuropathies and other disorders of the peripheral nervous system

173

680

2.57

29.17

1.4

1.3

1.19

1.47

nmol/l

2.67

148

609

Acute renal failure

160

607

2.67

28.99

1.2

1.57

1.42

nmol/l

0.72

142

539

First line medication for Crohn's disease

728

2476

1.61

28.97

1.4

1.3

1.51

1.36

nmol/l

2.81

664

2237

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

139

491

2.88

28.95

1.4

1.3

1.44

1.49

nmol/l

0.17

129

437

Acidosis

8.99

28.62

1.4

1.2

1.12

1.78

nmol/l

1.91

Amputation of toe

195

4.09

28.12

1.4

1.2

1.17

1.41

nmol/l

1.22

169

Asthma (only as main-diagnosis)

481

1642

1.77

28.06

1.4

1.3

1.63

1.36

nmol/l

5.15

443

1478

Alcohol dependence

218

968

2.27

28.02

1.4

1.3

1.42

1.41

nmol/l

0.01

192

867

Anxiety (asthma-related co-morbidities)

384

1628

1.87

27.94

1.3

1.54

1.41

nmol/l

1.31

355

1461

Nutritional anaemias

300

1465

2.00

27.83

1.4

1.3

1.41

1.44

nmol/l

0.17

268

1321

Emotionally unstable personality disorder

102

308

3.35

27.75

1.4

1.5

1.69

1.45

nmol/l

1.10

287

Diarrhoea and gastroenteritis of presumed infectious origin

456

2372

1.75

27.66

1.4

1.3

1.52

1.41

nmol/l

1.27

396

2155

Other and unspecified iron deficiency

211

931

2.28

27.48

1.4

1.3

1.45

1.48

nmol/l

0.14

186

833

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

187

783

2.41

27.47

1.4

1.3

1.40

1.41

nmol/l

0.03

170

701

Asthma (diagnoses ohter than nonallergic)

543

2795

1.67

27.15

1.4

1.3

1.58

1.40

nmol/l

3.21

505

2520

Implicit viral Sepsis

141

520

2.74

27.02

1.2

1.3

1.66

1.44

nmol/l

1.20

129

460

Viral Sepsis

141

521

2.74

26.92

1.2

1.3

1.66

1.44

nmol/l

1.20

129

461

Iron deficiency anaemia

258

1236

2.08

26.62

1.4

1.3

1.47

1.45

nmol/l

0.11

230

1110

Asthma, including avohilmo

744

2778

1.56

26.50

1.3

1.56

1.39

nmol/l

3.55

679

2508

Specific personality disorders

176

731

2.43

26.39

1.3

1.4

1.64

1.41

nmol/l

1.70

162

657

Diseases of the eye and adnexa

560

1667

1.69

26.35

1.4

1.3

1.47

1.45

nmol/l

0.15

487

1550

Bipolar affective disorders

143

539

2.68

26.27

1.2

1.4

1.73

1.40

nmol/l

2.23

135

481

Care involving dialysis

242

3.63

26.21

1.3

1.66

1.50

nmol/l

0.41

211

Spondylopathies

522

1876

1.70

26.13

1.4

1.3

1.55

1.38

nmol/l

2.52

483

1681

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

154

4.35

26.01

1.5

1.4

1.72

1.45

nmol/l

1.20

140

Neurotic, stress-related and somatoform disorders

563

2440

1.65

25.98

1.4

1.3

1.53

1.41

nmol/l

1.72

516

2198

L04AA Selective immunosuppressants

165

671

2.48

25.94

1.4

1.3

1.55

1.47

nmol/l

0.40

146

600

Other heart diseases, wide

601

2296

1.63

25.94

1.4

1.3

1.57

1.40

nmol/l

2.73

542

2076

Arthropathies in other diseases classified elsewhere

5.54

25.84

1.3

1.2

1.02

1.52

nmol/l

1.85

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

130

474

2.77

25.50

1.4

1.31

1.41

nmol/l

0.46

117

427

Pain in limb

484

2069

1.70

25.22

1.4

1.3

1.51

1.41

nmol/l

1.22

440

1881

Anxiety disorders

566

2472

1.63

25.04

1.4

1.3

1.54

1.40

nmol/l

2.00

519

2227

Asthma-related pneumonia

221

1033

2.15

24.95

1.3

1.57

1.40

nmol/l

1.42

205

927

Medical observation and evaluation for suspected diseases and conditions

427

1225

1.79

24.85

1.5

1.3

1.44

1.41

nmol/l

0.22

388

1112

Asthma, hospital admissions 3, pneumonia

221

1035

2.15

24.82

1.3

1.57

1.40

nmol/l

1.43

205

928

Asthma-related pneumonia or sepsis

221

1035

2.15

24.82

1.3

1.57

1.40

nmol/l

1.43

205

928

Alcoholic liver disease

100

322

3.16

24.62

1.3

1.31

1.47

nmol/l

0.60

288

Depression or dysthymia

458

1480

1.74

24.59

1.4

1.3

1.42

1.37

nmol/l

0.41

418

1341

Oral corticosteroids

676

2623

1.56

24.56

1.4

1.3

1.67

1.37

nmol/l

8.80

618

2369

Pain, not elsewhere classified

182

794

2.31

24.44

1.4

1.3

1.63

1.43

nmol/l

1.25

167

712

Chronic lower respiratory diseases

762

2704

1.53

24.42

1.4

1.3

1.54

1.39

nmol/l

2.93

696

2439

Other disorders of skin and subcutaneous tissue

417

2215

1.73

24.32

1.4

1.3

1.42

1.44

nmol/l

0.11

357

2010

Hernia of abdominal wall, postoperative

136

521

2.64

24.24

1.6

1.2

1.53

1.38

nmol/l

0.80

119

470

Persons encountering health services for examination and investigation

432

1225

1.77

24.23

1.3

1.48

1.41

nmol/l

0.62

389

1112

Persons encountering health services for specific procedures, not carried out

208

3.72

24.14

1.4

1.36

1.39

nmol/l

0.09

185

Other reaction to severe stress, and adjustment disorders

239

1168

2.06

24.10

1.5

1.4

1.47

1.45

nmol/l

0.11

218

1044

Dental caries 3

494

1490

1.70

24.05

1.4

1.3

1.44

nmol/l

0.02

442

1351

Shoulder lesions

505

1862

1.67

23.80

1.4

1.3

1.48

1.41

nmol/l

0.65

444

1690

Asthma, unspecified (mode), excluding more controls

328

1388

1.86

23.79

1.4

1.3

1.58

1.36

nmol/l

2.60

302

1257

Inflammatory bowel disease treatment related agents

721

2677

1.53

23.78

1.4

1.3

1.61

1.37

nmol/l

6.62

660

2418

Dental pulpitis 2, only avohilmo

428

1246

1.76

23.69

1.3

1.44

nmol/l

0.01

381

1135

Dental pulpitis 2

419

1214

1.77

23.61

1.3

1.46

1.42

nmol/l

0.23

372

1103

Other CVD (FINNGEN)

144

3.98

23.55

1.5

1.3

1.34

1.14

nmol/l

0.86

131

Senile cataract

408

1444

1.76

23.42

1.3

1.43

1.45

nmol/l

0.08

368

1318

Other cataract

278

1107

1.96

23.21

1.3

1.38

1.44

nmol/l

0.43

235

1007

Selective serotonin reuptake inhibitors

638

2140

1.57

23.17

1.4

1.3

1.50

1.37

nmol/l

2.21

569

1943

Polyarthropathies

452

1784

1.70

23.09

1.3

1.64

1.38

nmol/l

4.52

405

1622

Unstable angina pectoris

249

1028

2.02

23.08

1.2

1.3

1.56

1.37

nmol/l

1.80

225

926

All anxiety disorders

387

1788

1.75

22.93

1.3

1.54

1.40

nmol/l

1.50

357

1608

Dental caries, including avohilmo

463

1391

1.71

22.91

1.3

1.45

nmol/l

0.03

411

1260

Dental caries 1, only avohilmo

478

1455

1.69

22.59

1.3

1.45

nmol/l

0.01

426

1318

Dental caries 1

462

1393

1.70

22.56

1.3

1.45

nmol/l

0.02

410

1262

Peripheral arterial reconstruction

126

483

2.64

22.49

1.4

1.2

1.16

1.49

nmol/l

2.94

109

431

Intracranial trauma

335

1380

1.82

22.41

1.4

1.3

1.53

1.33

nmol/l

2.31

298

1252

Major coronary heart disease event excluding revascularizations

411

1655

1.72

22.38

1.2

1.3

1.52

1.36

nmol/l

2.06

370

1497

Volume depletion

219

3.52

22.35

1.4

1.2

1.44

1.40

nmol/l

0.09

192

Non-selective monoamine reuptake inhibitors

244

1197

1.99

22.30

1.3

1.64

1.37

nmol/l

2.72

221

1080

Dental caries 3, only avohilmo

500

1553

1.65

21.93

1.4

1.3

1.44

nmol/l

0.01

446

1408

Gout

197

842

2.15

21.89

1.2

1.87

1.32

nmol/l

6.92

184

768

Dialysis

104

4.84

21.84

1.6

1.2

1.39

1.53

nmol/l

0.33

Parodontitis or operation codes

566

2670

1.57

21.57

1.3

1.41

1.44

nmol/l

0.26

504

2421

Cystitis

497

1870

1.63

21.56

1.3

1.52

1.44

nmol/l

0.92

443

1695

Parodontitis

565

2670

1.57

21.45

1.3

1.41

1.44

nmol/l

0.26

503

2421

Amputation of foot

6.19

21.37

1.4

1.2

1.28

1.65

nmol/l

0.85

Gout, FINNGEN

197

939

2.12

21.35

1.2

1.3

1.87

1.35

nmol/l

6.42

184

844

Osteomyelitis

193

3.65

21.31

1.3

1.2

1.36

1.41

nmol/l

0.10

171

Intestinal infectious diseases

567

2845

1.56

21.18

1.4

1.3

1.49

1.42

nmol/l

0.64

493

2594

Oxycodone

219

1051

2.03

21.14

1.4

1.3

1.59

1.38

nmol/l

1.81

200

955

Heart failure, strict

356

1464

1.76

21.07

1.2

1.3

1.66

1.38

nmol/l

4.06

317

1332

Redundant prepuce, phimosis and paraphimosis

171

772

2.23

21.03

1.4

1.3

1.31

1.37

nmol/l

0.36

154

695

Other dorsopathies, not elsewhere classified

629

2160

1.54

20.89

1.3

1.52

1.38

nmol/l

2.20

578

1944

Carpal tunnel syndrome

365

1924

1.72

20.81

1.4

1.3

1.60

1.42

nmol/l

2.24

326

1740

Other anxiety disorders

276

1315

1.87

20.76

1.4

1.3

1.49

1.44

nmol/l

0.35

255

1182

Chronic periodontitis, including avohilmo

560

2672

1.56

20.76

1.3

1.42

1.44

nmol/l

0.21

499

2422

Concussion

287

1350

1.85

20.71

1.4

1.3

1.58

1.32

nmol/l

2.92

255

1224

Dermatitis

366

2154

1.71

20.61

1.4

1.3

1.56

1.43

nmol/l

1.41

332

1947

GI-bleeding

200

974

2.07

20.46

1.3

1.2

1.49

1.42

nmol/l

0.37

180

873

Gastrointestinal diseases

364

1033

1.77

20.43

1.4

1.3

1.41

1.42

nmol/l

0.07

331

933

Bleeding

504

2316

1.59

20.38

1.3

1.46

1.42

nmol/l

0.33

439

2106

Myocardial infarction

310

1233

1.81

20.36

1.2

1.3

1.49

1.34

nmol/l

1.59

277

1118

Asthma, unspecified (mode)

328

1473

1.77

20.35

1.4

1.3

1.58

1.37

nmol/l

2.34

302

1329

Other and unspecified dermatitis

305

1714

1.79

20.25

1.4

1.3

1.53

1.41

nmol/l

0.96

278

1539

Asthma, hospital admissions , main diagnosis only

492

2796

1.58

20.17

1.4

1.3

1.63

1.40

nmol/l

4.41

454

2529

ILD medications: immunosuppressive drugs

382

2201

1.67

19.80

1.3

1.55

1.38

nmol/l

2.27

342

1984

Other diseases of intestines

655

2543

1.50

19.75

1.4

1.3

1.51

1.40

nmol/l

1.62

591

2302

Schizophrenia or delusion, excluding more controls

193

933

2.06

19.72

1.3

1.65

1.42

nmol/l

1.82

173

834

Cellulitis

151

671

2.27

19.56

1.4

1.3

1.48

1.47

nmol/l

0.03

136

603

Other diseases of the digestive system

196

964

2.05

19.56

1.3

1.2

1.51

1.43

nmol/l

0.39

177

865

Benzodiazepine use

606

2864

1.51

19.52

1.4

1.3

1.57

1.41

nmol/l

2.82

539

2598

Substance use, excluding alcohol

140

603

2.34

19.51

1.4

1.3

1.30

1.47

nmol/l

1.02

127

540

All-cause Heart Failure

344

1435

1.74

19.50

1.2

1.3

1.65

1.38

nmol/l

3.77

305

1308

COPD/asthma related infections

639

2120

1.51

19.40

1.5

1.3

1.47

1.39

nmol/l

1.17

581

1918

COPD/asthma/ILD related infections

639

2120

1.51

19.40

1.5

1.3

1.47

1.39

nmol/l

1.17

581

1918

Pain (limb, back, neck, head abdominally)

461

1420

1.63

19.28

1.3

1.47

1.38

nmol/l

1.01

416

1272

Kela-code for severe mental illness

247

1325

1.88

19.13

1.3

1.4

1.67

1.44

nmol/l

2.26

224

1189

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

187

912

2.06

19.11

1.4

1.40

1.48

nmol/l

0.43

170

810

Gestational [pregnancy-induced] hypertension

140

607

2.32

19.09

1.5

1.4

1.70

1.46

nmol/l

1.58

125

546

Other intervertebral disc disorders

514

2015

1.57

19.01

1.4

1.3

1.58

1.38

nmol/l

2.97

470

1808

Coronary artery bypass grafting

181

655

2.12

18.79

1.2

1.55

1.31

nmol/l

2.09

164

589

Recurrent or chronic depression

252

970

1.89

18.78

1.5

1.3

1.37

nmol/l

0.01

227

879

Unspecified mental disorder

266

1470

1.82

18.72

1.4

1.63

1.44

nmol/l

1.86

241

1324

Headache

376

1898

1.66

18.72

1.4

1.3

1.64

1.40

nmol/l

3.71

343

1708

Suicide or other Intentional self-harm

164

769

2.15

18.62

1.4

1.38

1.46

nmol/l

0.41

150

684

Oedema, not elsewhere classified

187

918

2.04

18.50

1.4

1.3

1.49

1.39

nmol/l

0.62

166

824

Soft tissue disorders

624

2163

1.50

18.49

1.4

1.3

1.50

1.40

nmol/l

1.35

556

1968

Dental caries 3 and operation codes

532

1759

1.56

18.44

1.3

1.45

1.44

nmol/l

0.02

479

1598

Diseases of pulp and periapical tissues

229

1218

1.89

18.25

1.3

1.41

1.44

nmol/l

0.14

209

1099

Amputation of ankle bones

6.29

18.24

1.3

1.1

1.55

1.76

nmol/l

0.38

Hypothyreosis and Thyroxine purchase for inclusion criteria

536

2317

1.53

18.22

1.3

1.49

1.43

nmol/l

0.62

472

2110

Hypothyroidism, strict autoimmune, 3 medication purchases required

482

2106

1.57

18.20

1.3

1.50

1.43

nmol/l

0.68

424

1913

Bacterial infection, other or unspecified

298

1543

1.75

18.15

1.3

1.32

1.40

nmol/l

0.61

265

1401

Covid-19 confirmed case

183

903

2.04

18.15

1.3

1.51

1.44

nmol/l

0.40

167

808

Hyperkalaemia

121

4.12

18.06

1.3

1.1

1.70

1.43

nmol/l

0.73

107

Other headache syndromes

238

1286

1.86

18.04

1.4

1.3

1.47

1.36

nmol/l

0.94

218

1145

Polycystic ovarian syndrome, consortium definition

356

1271

1.70

18.00

1.4

1.61

1.46

nmol/l

1.51

327

1146

Rotator cuff syndrome

380

1719

1.65

17.99

1.4

1.3

1.48

1.41

nmol/l

0.51

333

1558

Other gastritis (incl. Duodenitis)

154

715

2.17

17.96

1.3

1.55

1.46

nmol/l

0.43

141

636

Disorders of other endocrine glands

254

1379

1.82

17.94

1.3

1.57

1.45

nmol/l

0.95

233

1234

Myocardial infarction, strict

284

1165

1.79

17.91

1.2

1.3

1.49

1.35

nmol/l

1.37

255

1058

Panic disorder

100

384

2.63

17.87

1.4

1.54

1.38

nmol/l

0.66

346

Other disorders of urethra and urinary system

383

1757

1.64

17.78

1.4

1.3

1.51

1.44

nmol/l

0.58

352

1591

Spondylosis

329

1671

1.70

17.78

1.4

1.3

1.48

1.40

nmol/l

0.78

303

1495

Symptoms and signs involving cognition, perception, emotional state and behaviour

575

2702

1.50

17.71

1.3

1.46

1.44

nmol/l

0.22

522

2434

Paroxysmal tachycardia

114

389

2.49

17.71

1.5

1.4

1.56

1.24

nmol/l

1.94

100

352

Myocardial infarction, without ST-elevation

238

1192

1.85

17.58

1.2

1.46

1.41

nmol/l

0.34

215

1075

Lumbar disc prolapse

394

1944

1.62

17.49

1.4

1.3

1.62

1.39

nmol/l

3.29

358

1743

Allergic asthma (mode), excluding more controls

146

660

2.18

17.30

1.4

1.3

1.55

1.39

nmol/l

0.97

135

591

Dermatitis and eczema

642

2897

1.46

17.15

1.4

1.3

1.52

1.42

nmol/l

1.46

584

2619

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

238

626

1.91

17.09

1.3

1.47

1.39

nmol/l

0.49

214

553

Factors influencing health status and contact with health services

211

533

1.99

17.01

1.3

1.34

1.41

nmol/l

0.37

193

482

Other dialysis

4.73

16.91

1.4

1.2

1.31

1.47

nmol/l

0.34

Hypothyroidism, other/unspecified

518

2262

1.52

16.87

1.3

1.49

1.43

nmol/l

0.56

455

2061

Dental caries 1 and operation codes

504

1681

1.54

16.86

1.3

1.44

1.45

nmol/l

0.06

451

1525

Parodontitis and operation codes

516

2673

1.51

16.72

1.3

1.40

1.44

nmol/l

0.39

460

2420

Oesophageal varices

107

4.21

16.60

1.3

1.2

1.78

1.47

nmol/l

0.81

Mycoses

167

825

2.04

16.58

1.2

1.3

1.42

1.49

nmol/l

0.32

150

739

664

2427

1.45

16.53

1.4

1.3

1.54

1.40

nmol/l

2.41

603

2196

Hypo-osmolality and hyponatraemia

106

434

2.46

16.50

1.3

1.10

1.45

nmol/l

3.53

388

Gastroduodenal ulcer

164

807

2.04

16.33

1.4

1.2

1.56

1.43

nmol/l

0.67

147

727

Other acute lower respiratory infections

309

1767

1.68

16.29

1.4

1.3

1.50

1.42

nmol/l

0.62

284

1588

Use of hypnotics and sedatives

653

2626

1.44

16.17

1.3

1.47

1.43

nmol/l

0.44

584

2378

Allergic asthma (mode)

146

681

2.12

16.02

1.4

1.3

1.55

1.41

nmol/l

0.75

135

609

Gout, idiopatic and unspecified

163

810

2.03

15.96

1.2

1.97

1.36

nmol/l

6.34

152

725

Disorders of the thyroid gland

552

2450

1.48

15.84

1.3

1.48

1.42

nmol/l

0.54

484

2232

Other and unspecified anaemias

230

1240

1.80

15.77

1.3

1.40

1.41

nmol/l

0.07

208

1114

Genitourinary diseases

404

1270

1.60

15.76

1.3

1.50

1.33

nmol/l

2.17

361

1158

Maternal care for other known or suspected fetal problems

125

347

2.32

15.69

1.6

1.4

1.62

1.48

nmol/l

0.59

113

310

Symptoms and signs concerning food and fluid intake

272

2.82

15.61

1.6

1.3

1.20

1.51

nmol/l

1.93

245

Benign neoplasm of other and ill-defined parts of digestive system

119

528

2.27

15.60

1.4

1.3

1.52

1.48

nmol/l

0.11

110

471

Chronic periapical parodontitis

137

646

2.14

15.44

1.3

1.41

1.42

nmol/l

0.05

123

579

Problems related to lifestyle

274

2.80

15.44

1.5

1.3

1.34

1.40

nmol/l

0.18

246

Complications of medical and surgical care

414

2562

1.54

15.38

1.5

1.3

1.50

1.43

nmol/l

0.72

371

2313

Dorsopathies

614

2166

1.45

15.34

1.4

1.3

1.55

1.38

nmol/l

3.20

568

1950

Heart failure and coronary heart disease

184

708

1.95

15.31

1.3

1.2

1.69

1.37

nmol/l

2.66

162

629

Preparatory care for dialysis

123

3.83

15.28

1.2

1.79

1.43

nmol/l

0.77

110

Other anaemias

230

1249

1.79

15.27

1.3

1.40

1.41

nmol/l

0.08

208

1123

Erythema intertrigo

5.76

15.16

1.3

1.2

1.96

1.38

nmol/l

1.33

Other diseases of urinary system

595

2315

1.45

15.14

1.3

1.47

1.43

nmol/l

0.43

532

2098

Irregular menses

237

1085

1.78

15.13

1.5

1.4

1.65

1.46

nmol/l

1.81

222

981

Benign neoplasm of other and ill-defined parts of digestive system

119

535

2.24

15.13

1.4

1.3

1.52

1.46

nmol/l

0.20

110

482

Chronic ulcer of skin, not elsewhere classified

177

3.27

15.06

1.4

1.3

1.47

1.44

nmol/l

0.06

155

Diseases of oral cavity, salivary glands and jaws

536

1863

1.48

14.86

1.4

1.3

1.43

1.44

nmol/l

0.05

478

1684

Bronchitis

608

2795

1.43

14.82

1.4

1.3

1.53

1.40

nmol/l

2.07

555

2527

Extracorporeal dialysis

169

3.31

14.80

1.4

1.2

1.54

1.36

nmol/l

0.39

148

Acute upper respiratory infections

596

2605

1.44

14.79

1.5

1.3

1.52

1.41

nmol/l

1.35

541

2355

Gout, strict definition

125

580

2.18

14.73

1.2

2.08

1.41

nmol/l

5.52

115

512

Pruritus

271

2.76

14.62

1.4

1.59

1.44

nmol/l

0.49

248

Gingivitis and periodontal diseases

529

1860

1.47

14.34

1.3

1.42

1.44

nmol/l

0.20

467

1681

Fibrosis and cirrhosis of liver

220

2.95

14.26

1.3

1.59

1.47

nmol/l

0.30

195

Other functional intestinal disorders

247

1387

1.70

13.92

1.4

1.3

1.55

1.39

nmol/l

1.27

224

1247

Spinal stenosis

294

1414

1.64

13.80

1.3

1.2

1.61

1.40

nmol/l

2.20

270

1269

Symptoms and signs involving the nervous and musculoskeletal systems

320

2022

1.59

13.80

1.4

1.3

1.59

1.41

nmol/l

2.28

286

1828

Other pulmonary diagnosis

492

1666

1.48

13.77

1.4

1.3

1.49

1.36

nmol/l

1.57

441

1499

Persistent mood disorders

117

544

2.17

13.72

1.4

1.3

1.61

1.45

nmol/l

0.73

105

485

Acute sinusitis

298

1726

1.62

13.68

1.5

1.3

1.49

1.43

nmol/l

0.42

267

1551

Alcohol abuse, main dg, excluding more controls

104

463

2.27

13.59

1.4

1.3

1.17

1.42

nmol/l

1.85

414

Aplastic and other anaemias

239

1334

1.71

13.57

1.3

1.42

nmol/l

0.02

215

1203

Excluding asthma or asthma-COPD overlap

490

1666

1.48

13.46

1.4

1.3

1.48

1.36

nmol/l

1.53

438

1499

Pre-eclampsia or eclampsia

117

552

2.13

13.23

1.4

1.60

1.46

nmol/l

0.70

108

502

Schizophrenia or delusion

193

1081

1.79

13.19

1.3

1.4

1.65

1.46

nmol/l

1.36

173

969

Benign neoplasm of colon, rectum, anus and anal canal

342

2001

1.55

13.05

1.4

1.3

1.53

1.41

nmol/l

1.01

313

1804

Hernia of abdominal wall

273

1687

1.63

13.00

1.4

1.3

1.57

1.40

nmol/l

1.53

246

1528

Other medical care

221

1261

1.72

12.98

1.2

1.3

1.46

1.41

nmol/l

0.28

193

1150

Schizophrenia, schizotypal and delusional disorders

193

1087

1.78

12.96

1.3

1.4

1.65

1.46

nmol/l

1.37

173

974

Exclusions for E4_PCOS_BROAD

108

498

2.18

12.95

1.3

1.63

1.45

nmol/l

0.84

100

452

Acute upper respiratory infections of multiple and unspecified sites

414

2090

1.49

12.79

1.4

1.3

1.56

1.40

nmol/l

1.94

374

1887

Phobic anxiety disorders

321

2.48

12.69

1.2

1.4

1.64

1.35

nmol/l

1.12

296

Trigger finger

407

2.30

12.69

1.3

1.44

1.51

nmol/l

0.26

367

Pre-eclampsia or poor fetal growth

152

799

1.91

12.63

1.5

1.4

1.57

1.49

nmol/l

0.41

139

717

Acute bronchitis

224

1299

1.70

12.58

1.4

1.3

1.49

1.42

nmol/l

0.41

207

1167

Asthma/COPD (KELA code 203)

537

2687

1.41

12.46

1.3

1.59

1.39

nmol/l

3.39

492

2422

Other and unspecified effects of external causes

158

851

1.87

12.31

1.6

1.4

1.66

1.45

nmol/l

1.24

141

761

Vitreous haemorrhage

309

2.49

12.26

1.3

1.25

1.45

nmol/l

0.81

276

Heart failure and bmi 25plus

206

817

1.75

12.09

1.2

1.63

1.43

nmol/l

1.53

183

741

Fracture of lower leg, including ankle

308

1984

1.55

12.09

1.4

1.3

1.44

1.42

nmol/l

0.13

274

1795

Gout, unspecified

129

657

1.98

11.93

1.1

1.2

2.04

1.39

nmol/l

5.74

119

586

COPD differential diagnosis

480

1668

1.44

11.87

1.4

1.3

1.48

1.36

nmol/l

1.36

431

1499

Autoimmune diseases related-to ILD

476

2956

1.42

11.82

1.4

1.3

1.54

1.42

nmol/l

1.56

427

2678

Other and unspecified local infections of skin and subcutaneous tissue

261

2.59

11.82

1.3

1.28

1.48

nmol/l

0.76

235

Injuries to the knee and lower leg

669

2829

1.36

11.79

1.3

1.45

1.43

nmol/l

0.11

606

2560

Pre-eclampsia

105

500

2.11

11.66

1.4

1.64

1.46

nmol/l

0.89

453

All influenza

147

788

1.88

11.65

1.3

1.57

1.42

nmol/l

0.97

135

701

ILD differential diagnosis

478

1668

1.44

11.57

1.4

1.3

1.48

1.36

nmol/l

1.34

430

1499

Injuries to the ankle and foot

383

2380

1.47

11.52

1.4

1.3

1.55

1.40

nmol/l

1.67

347

2148

Diabetic nephropathy, excluding more controls

251

1307

1.63

11.49

1.3

1.40

1.47

nmol/l

0.36

211

1194

Presence of other functional implants

302

1387

1.55

11.15

1.4

1.3

1.38

1.41

nmol/l

0.24

262

1255

Other metabolic disorders

299

2.43

11.11

1.3

1.4

1.31

1.44

nmol/l

0.42

266

Other and unspecified nonorganic psychotic disorders

117

591

1.99

11.10

1.3

1.4

1.61

1.41

nmol/l

1.00

103

537

Fall on same level

661

2752

1.34

11.00

1.4

1.3

1.44

1.43

nmol/l

0.07

597

2490

Other/unspecified dorsalgia

204

1218

1.67

10.98

1.4

1.3

1.54

1.37

nmol/l

1.28

183

1078

Constipation

476

2431

1.41

10.89

1.3

1.55

1.42

nmol/l

1.68

434

2191

Adverse effects, not elsewhere classified

111

555

2.01

10.85

1.6

1.3

1.72

1.45

nmol/l

1.54

499

Other local infections of skin and subcutaneous tissue

285

2.45

10.80

1.3

1.27

1.49

nmol/l

0.90

258

Other symptoms and signs involving the nervous and musculoskeletal systems

226

1399

1.62

10.78

1.5

1.3

1.66

1.42

nmol/l

2.42

198

1262

Benign neoplasm: Colon

283

1809

1.54

10.71

1.4

1.3

1.55

1.40

nmol/l

1.36

260

1632

Pain in joint

311

1356

1.52

10.60

1.4

1.3

1.50

1.39

nmol/l

1.01

280

1212

Benign neoplasm: Colon

281

1397

1.55

10.55

1.4

1.3

1.55

1.41

nmol/l

1.15

259

1260

Benign neoplasm of colon, rectum, anus and anal canal

321

1528

1.51

10.52

1.4

1.3

1.53

1.43

nmol/l

0.84

293

1377

Chronic periodontitis

441

2.13

10.51

1.2

1.3

1.51

1.43

nmol/l

0.24

397

Amenorrhoea

136

3.12

10.44

1.5

1.63

1.42

nmol/l

0.58

121

Finngen Rheumatological endpoints

558

2331

1.37

10.43

1.3

1.59

1.36

nmol/l

4.73

499

2110

Chronic gastritis

149

832

1.80

10.41

1.3

1.39

1.44

nmol/l

0.27

135

746

Ascites

185

2.79

10.39

1.3

1.2

1.40

1.54

nmol/l

0.31

166

Benign neoplasms

571

2345

1.36

10.38

1.4

1.3

1.48

1.40

nmol/l

0.86

521

2113

Presence of cardiac and vascular implants and grafts

253

1223

1.57

10.17

1.3

1.60

1.39

nmol/l

2.13

236

1104

Other obstetric conditions, not elsewhere classified

141

495

1.86

10.11

1.6

1.5

1.50

1.51

nmol/l

0.05

130

445

Disorders of skin appendages

256

1659

1.55

10.05

1.4

1.3

1.54

1.42

nmol/l

0.97

224

1500

Diseases of the musculoskeletal system and connective tissue

319

1060

1.51

10.03

1.3

1.42

1.36

nmol/l

0.36

282

968

Psoriasis

169

990

1.72

10.03

1.3

1.66

1.44

nmol/l

1.63

153

887

Acute peritonitis

172

2.83

10.03

1.4

1.3

1.32

1.42

nmol/l

0.27

151

Streptococcal septicaemia

224

2.57

9.95

1.1

1.2

1.52

1.50

nmol/l

0.05

199

Explicit bacterial Sepsis

284

2.38

9.93

1.1

1.3

1.48

1.50

nmol/l

0.05

255

315

2.30

9.92

1.8

1.3

1.31

1.45

nmol/l

0.55

284

Provisional assignment of new diseases of uncertain etiology

236

1508

1.57

9.89

1.3

1.4

1.49

1.44

nmol/l

0.29

217

1353

Codes for special purposes

236

1508

1.57

9.89

1.3

1.4

1.49

1.44

nmol/l

0.29

217

1353

Candidiasis

367

2.20

9.86

1.2

1.3

1.46

1.48

nmol/l

0.05

331

Urolithiasis

183

1102

1.67

9.80

1.2

1.3

1.61

1.40

nmol/l

1.72

168

991

Alcohol abuse, main dg

104

528

1.98

9.80

1.4

1.3

1.17

1.46

nmol/l

2.28

476

Other neurological diseases

379

2137

1.43

9.77

1.3

1.42

1.43

nmol/l

0.06

330

1939

Otitis externa

123

661

1.87

9.77

1.5

1.3

1.51

1.49

nmol/l

0.08

107

591

Dizziness and giddiness

394

2260

1.42

9.75

1.3

1.48

1.43

nmol/l

0.37

362

2039

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

253

1275

1.55

9.74

1.3

1.31

1.43

nmol/l

0.86

225

1156

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

135

475

1.85

9.62

1.5

1.52

1.51

nmol/l

0.02

124

425

Superficial injury of head

122

659

1.86

9.54

1.4

1.3

1.35

1.43

nmol/l

0.38

111

586

Acute alcohol intoxication

150

864

1.75

9.48

1.4

1.3

1.19

1.45

nmol/l

2.51

142

769

Behavioural syndromes associated with physiological disturbances and physical factors

167

991

1.69

9.44

1.3

1.4

1.50

1.46

nmol/l

0.18

153

892

Benign neoplasms

459

1876

1.39

9.42

1.4

1.3

1.46

1.41

nmol/l

0.37

417

1692

Disorders of sclera, cornea, iris and ciliary body

294

1992

1.48

9.41

1.4

1.3

1.48

1.41

nmol/l

0.48

260

1797

Schizoaffective disorder

219

2.54

9.37

1.2

1.4

1.47

1.42

nmol/l

0.16

202

Diseases of external ear

179

1086

1.66

9.34

1.4

1.3

1.46

1.43

nmol/l

0.11

158

972

Injuries to the head

596

2941

1.32

9.22

1.4

1.3

1.42

1.43

nmol/l

0.12

543

2660

Calculus of kidney and ureter

170

1022

1.67

9.20

1.3

1.62

1.40

nmol/l

1.81

156

914

Dental operations

368

1313

1.44

9.20

1.3

1.51

1.43

nmol/l

0.56

330

1189

Sequelae of external causes of morbidity and mortality

139

792

1.76

9.15

1.6

1.2

1.49

1.48

nmol/l

0.02

127

708

Acute pharyngitis

402

2.09

9.14

1.3

1.15

1.41

nmol/l

1.86

364

Radiculopathy

481

1.99

9.05

1.3

1.58

1.44

nmol/l

0.46

421

Unspecified acute lower respiratory infection

461

2.01

9.03

1.3

1.49

1.43

nmol/l

0.20

410

Adenocarcinoma and ductal carcinoma of pancreas

3.60

8.99

1.1

1.2

1.05

1.45

nmol/l

0.99

Cervicobrachial syndrome

123

680

1.82

8.97

1.3

1.58

1.43

nmol/l

0.65

118

603

Open wound of ankle and foot

298

2.27

8.95

1.4

1.3

1.42

nmol/l

0.00

267

Injuries to the thorax

239

1573

1.52

8.83

1.4

1.3

1.21

1.41

nmol/l

2.78

218

1413

Other postsurgical states

173

2.69

8.81

2.4

1.2

1.55

1.54

nmol/l

0.03

150

Excessive, frequent and irregular menstruation

193

657

1.64

8.78

1.5

1.3

1.67

1.38

nmol/l

2.86

167

588

Papulosquamous disorders

214

1384

1.55

8.60

1.3

1.59

1.43

nmol/l

1.39

191

1244

Social phobias

181

2.62

8.58

1.3

1.4

1.47

1.39

nmol/l

0.15

170

Migraine

222

1226

1.54

8.54

1.5

1.4

1.59

1.36

nmol/l

2.60

206

1101

Convulsions, not elsewhere classified

125

698

1.78

8.45

1.5

1.3

1.21

1.39

nmol/l

1.10

113

623

Sequelae with surgical and medical care as external cause

112

614

1.84

8.43

1.6

1.3

1.48

1.49

nmol/l

0.01

103

545

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

315

2202

1.43

8.43

1.5

1.3

1.51

1.42

nmol/l

0.74

286

1988

Postprocedural endocrine and metabolic disorders, not elsewhere classified

274

2.28

8.42

1.3

1.4

1.34

1.44

nmol/l

0.28

243

Prurigo nodularis

4.05

8.37

1.3

1.4

1.63

1.36

nmol/l

0.49

Psoriasis vulgaris

114

630

1.82

8.37

1.3

1.71

1.46

nmol/l

1.53

102

566

Diverticular disease of intestine

388

1863

1.39

8.25

1.3

1.56

1.40

nmol/l

1.77

349

1684

Diabetic retinopathy, excluding more controls

411

1690

1.38

8.18

1.3

1.16

1.48

nmol/l

7.84

334

1544

Hypokalaemia

299

2.19

8.04

1.4

1.3

1.55

1.45

nmol/l

0.24

265

Care involving use of rehabilitation procedures

333

2258

1.40

8.03

1.2

1.3

1.44

1.43

nmol/l

0.06

289

2055

Abnormalities of heart beat

169

1042

1.61

8.03

1.4

1.3

1.53

1.37

nmol/l

1.07

147

939

Schizophrenia

100

539

1.87

7.97

1.2

1.3

1.68

1.42

nmol/l

1.30

481

Myalgia

116

655

1.78

7.94

1.2

1.3

1.59

1.48

nmol/l

0.40

594

Umbilical hernia

163

1010

1.62

7.92

1.4

1.3

1.54

1.44

nmol/l

0.53

147

917

Dental operations, only avohilmo

383

1415

1.39

7.88

1.3

1.49

1.43

nmol/l

0.41

343

1278

Speech and linguistic disorders, excluding more controls

134

2.76

7.83

1.4

1.3

1.67

1.32

nmol/l

1.03

122

Diseases of the respiratory system

362

1296

1.40

7.83

1.4

1.2

1.49

1.36

nmol/l

1.15

324

1169

Pacemaker

156

931

1.64

7.82

1.4

1.2

1.53

1.42

nmol/l

0.62

139

838

Fracture of rib(s), sternum and thoracic spine

161

998

1.62

7.81

1.4

1.3

1.19

1.44

nmol/l

3.10

145

895

Persons encountering health services in other circumstances

177

1122

1.58

7.78

1.6

1.3

1.43

1.42

nmol/l

0.04

163

1016

Familial hypercholesterolemia

434

1.95

7.63

1.3

1.2

1.58

1.42

nmol/l

0.74

385

Urticaria and erythema

186

1200

1.56

7.61

1.6

1.3

1.59

1.44

nmol/l

0.82

170

1075

Mental and behavioural disorders due to sedatives or hypnotics

205

2.42

7.59

1.4

1.20

1.44

nmol/l

0.87

187

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

3.21

7.57

1.1

1.2

1.05

1.45

nmol/l

1.05

Deposits [accretions] on teeth

169

2.54

7.53

1.5

1.3

1.60

1.36

nmol/l

0.67

149

Vasomotor and allergic rhinitis

202

1311

1.52

7.51

1.3

1.61

1.44

nmol/l

1.16

180

1183

Certain disorders involving the immune mechanism

110

624

1.77

7.45

1.2

1.3

1.60

1.46

nmol/l

0.52

100

559

Diseases of peritoneum

296

2.15

7.43

1.4

1.3

1.37

1.50

nmol/l

0.52

265

Nonorganic sleeping disorders, excluding more controls

459

1.90

7.43

1.3

1.44

1.43

nmol/l

0.05

411

Gastric ulcer

532

1.83

7.35

1.4

1.2

1.59

1.50

nmol/l

0.31

470

Diabetic nephropathy

251

1721

1.46

7.34

1.3

1.40

nmol/l

0.01

211

1570

Falls/tendency to fall

627

2459

1.28

7.34

1.4

1.3

1.42

1.43

nmol/l

0.13

572

2222

Unspecified jaundice

115

2.90

7.33

1.2

1.20

1.53

nmol/l

0.98

103

Other diseases of hard tissues of teeth

330

1774

1.39

7.32

1.4

1.3

1.39

1.44

nmol/l

0.42

294

1598

Osteopathies and chondropathies

275

1835

1.43

7.28

1.5

1.3

1.54

1.41

nmol/l

0.95

245

1648

Other symptoms and signs involving cognitive functions and awareness

213

1338

1.50

7.28

1.4

1.3

1.41

1.40

nmol/l

0.02

190

1207

Cervical disc disorders

199

1317

1.52

7.28

1.4

1.3

1.66

1.40

nmol/l

2.06

177

1177

Migraine with aura

105

592

1.78

7.26

1.6

1.4

1.61

1.39

nmol/l

1.21

528

Parodontitis or/and operation codes

361

1564

1.38

7.25

1.3

1.4

1.37

1.45

nmol/l

0.52

319

1418

Gonarthrosis

371

1556

1.37

7.24

1.4

1.3

1.58

1.38

nmol/l

2.77

342

1415

Non-allergic asthma (mode), excluding more controls

100

552

1.80

7.19

1.4

1.2

1.50

1.34

nmol/l

0.96

497

Malignant neoplasm of prostate

1096

0.57

7.19

1.4

1.2

1.54

1.40

nmol/l

0.82

989

Visual disturbances and blindness

249

1730

1.44

7.13

1.4

1.3

1.45

1.42

nmol/l

0.12

223

1558

Other complications of surgical and medical care, not elsewhere classified

262

2.19

7.12

1.5

1.2

1.36

1.44

nmol/l

0.19

240

Cardiomyopathy

553

1.80

7.09

1.3

1.74

1.38

nmol/l

2.07

501

Rheumatism, unspecified

342

2.03

7.08

1.4

1.3

1.97

1.43

nmol/l

2.30

311

Injury, poisoning and certain other consequences of external causes

306

1085

1.42

7.06

1.4

1.3

1.52

1.40

nmol/l

1.05

278

988

Other problems related to primary support group, including family circumstances

262

2.17

7.05

1.3

1.4

1.65

1.43

nmol/l

0.61

240

Non-allergic asthma (mode)

100

556

1.79

7.03

1.4

1.2

1.50

1.39

nmol/l

0.55

499

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

285

2033

1.40

7.03

1.6

1.3

1.52

1.42

nmol/l

0.78

257

1834

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

107

2.94

7.03

1.6

1.4

0.99

1.55

nmol/l

2.35

100

Misadventures to patients during surgical and medical care

419

1.92

7.02

1.3

1.52

1.50

nmol/l

0.04

380

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

251

2.21

7.00

1.7

1.3

1.57

1.47

nmol/l

0.19

226

Use of disulfiram, acamprosate or naltrexone

324

2.06

6.98

1.3

1.51

1.45

nmol/l

0.17

297

Cardiomyopathies, Primary/intrinsic

400

1.94

6.93

1.2

1.82

1.38

nmol/l

2.12

360

Asthma and allergy, excluding more controls

314

2.05

6.90

1.3

1.51

1.33

nmol/l

0.63

283

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

433

1.86

6.89

1.3

1.5

1.68

1.34

nmol/l

1.62

402

Injuries to the abdomen, lower back, lumbar spine and pelvis

189

1245

1.51

6.86

1.6

1.3

1.23

1.44

nmol/l

2.05

171

1115

Other disorders of teeth and supporting structures

110

640

1.73

6.86

1.4

1.3

1.42

1.44

nmol/l

0.05

575

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

190

2.39

6.85

1.6

1.4

1.56

1.38

nmol/l

0.50

172

Viral infections characterized by skin and mucous membrane lesions

215

1464

1.47

6.84

1.3

1.57

1.41

nmol/l

1.53

194

1308

Cardiomyopathy (excluding other)

409

1.92

6.84

1.2

1.80

1.40

nmol/l

1.86

366

Early onset COPD, excluding more controls

119

708

1.69

6.83

1.5

1.2

1.57

1.38

nmol/l

0.96

112

646

Gonarthrosis [arthrosis of knee](FG)

424

1885

1.33

6.76

1.4

1.3

1.58

1.35

nmol/l

3.93

388

1702

malignant neoplasm of male genital organs

105

1131

0.59

6.75

1.4

1.2

1.51

1.39

nmol/l

0.62

1022

Allergic rhinitis

152

955

1.58

6.75

1.3

1.4

1.66

1.42

nmol/l

1.56

137

860

Asthma and allergy

317

2.03

6.74

1.3

1.51

1.35

nmol/l

0.52

284

Diseases of the ear and mastoid process

653

2632

1.26

6.72

1.3

1.46

1.42

nmol/l

0.32

583

2397

Disorders of vitreous body and globe

243

1662

1.43

6.63

1.3

1.60

1.41

nmol/l

1.75

209

1501

Cough

193

1243

1.49

6.60

1.2

1.3

1.42

1.37

nmol/l

0.23

173

1125

Hernia

499

2632

1.29

6.59

1.4

1.3

1.43

nmol/l

0.05

447

2383

Corns and callosities

194

2.34

6.57

1.2

1.3

1.51

1.43

nmol/l

0.17

172

Open wound of lower leg

445

1.85

6.49

1.3

1.36

1.40

nmol/l

0.11

403

Dysphagia

113

673

1.69

6.49

1.5

1.2

1.40

1.43

nmol/l

0.11

101

595

Superficial injury of ankle and foot

299

2.05

6.49

1.3

1.48

1.45

nmol/l

0.07

270

Drug-induced adrenocortical insufficiency

4.00

6.48

1.4

1.1

2.08

1.43

nmol/l

1.03

Isolated proteinuria

3.18

6.47

1.8

1.2

1.86

1.45

nmol/l

1.01

Diabetic neuropathy

178

1182

1.52

6.44

1.4

1.3

1.23

1.42

nmol/l

1.75

158

1059

Accidents

478

1845

1.30

6.42

1.5

1.3

1.48

1.43

nmol/l

0.44

426

1668

Glaucoma suspect

170

1124

1.52

6.32

1.2

1.3

1.52

1.43

nmol/l

0.51

152

1011

Inflammatory diseases of female pelvic organs

255

1363

1.41

6.32

1.4

1.58

1.48

nmol/l

0.80

229

1235

Lesion of ulnar nerve

442

1.84

6.32

1.2

1.3

1.48

1.45

nmol/l

0.08

401

Abscess of anal and rectal regions

276

2.08

6.29

1.3

1.49

1.42

nmol/l

0.17

248

Other disorders of skin and subcutaneous tissue, not elsewhere classified

414

1.87

6.29

1.4

1.3

1.42

1.50

nmol/l

0.24

375

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

198

2.29

6.28

1.4

1.31

1.39

nmol/l

0.21

181

Degeneration of macula and posterior pole

197

1102

1.48

6.28

1.2

1.3

1.33

1.50

nmol/l

1.38

169

1013

Syncope and collapse

211

1289

1.45

6.26

1.4

1.3

1.42

nmol/l

0.02

192

1157

Cervicalgia

103

605

1.71

6.25

1.4

1.3

1.44

1.43

nmol/l

0.01

530

Other noninfective gastroenteritis and colitis

118

718

1.65

6.24

1.4

1.3

1.60

1.45

nmol/l

0.65

109

639

Other and unspecified tonsillitis

178

1006

1.51

6.23

1.4

1.3

1.52

1.39

nmol/l

0.85

165

905

Urticaria

145

930

1.56

6.19

1.6

1.4

1.52

1.48

nmol/l

0.16

131

830

Visual disturbances

230

1620

1.42

6.19

1.4

1.3

1.48

1.42

nmol/l

0.35

206

1457

Parodontitis, under 40 years

212

2.23

6.18

1.2

1.5

1.42

1.36

nmol/l

0.13

191

Infections of genitourinary tract in pregnancy

181

2.33

6.14

1.4

1.5

1.69

1.39

nmol/l

1.24

164

Arthropathies

500

1986

1.28

6.14

1.3

1.54

1.38

nmol/l

2.31

441

1812

Parodontitis, under 40 years, or operation codes

213

2.22

6.12

1.2

1.5

1.42

1.35

nmol/l

0.15

192

Intracranial injury

286

2027

1.37

6.03

1.4

1.3

1.52

1.42

nmol/l

0.78

256

1836

Personal history of other diseases and conditions

247

2.11

5.96

1.1

1.3

1.38

1.41

nmol/l

0.06

223

Generalized anxiety disorder

372

1.89

5.94

1.2

1.4

1.72

1.41

nmol/l

0.99

335

Unspecified privation

317

1.97

5.91

1.3

1.48

nmol/l

0.01

283

Other external causes of accidental injury

473

1845

1.29

5.91

1.5

1.3

1.47

1.43

nmol/l

0.33

422

1668

Malignant neoplasm of digestive organs

178

1188

1.48

5.87

1.3

1.2

1.33

1.40

nmol/l

0.35

157

1074

Direct fill therapy

395

1.86

5.87

1.2

1.3

1.38

1.40

nmol/l

0.05

358

Disorders of vitreous body

233

1626

1.41

5.86

1.4

1.3

1.58

1.41

nmol/l

1.47

199

1471

Other and unspecified drugs and medicaments

237

2.13

5.86

1.7

1.3

1.61

1.47

nmol/l

0.31

211

Exclusions for E4_PCOS_CONSORTIUM

331

1549

1.34

5.84

1.5

1.3

1.60

1.43

nmol/l

1.72

296

1402

Keratitis

177

1201

1.48

5.84

1.4

1.3

1.49

1.44

nmol/l

0.20

154

1075

AV-block

457

1.76

5.81

1.4

1.2

1.26

1.37

nmol/l

0.45

404

External causes of morbidity and mortality

374

1417

1.32

5.81

1.4

1.3

1.54

1.40

nmol/l

1.40

338

1288

Cholecystitis

376

1.87

5.76

1.2

1.3

1.35

1.48

nmol/l

0.41

332

Other specific joint derangements/joint disorders

379

1945

1.31

5.71

1.4

1.3

1.48

1.39

nmol/l

0.91

341

1772

Bell's palsy

350

1.90

5.67

1.4

1.3

1.44

1.45

nmol/l

0.06

314

Other keratitis

322

1.94

5.67

1.4

1.3

1.49

1.43

nmol/l

0.14

294

Ventral hernia

122

770

1.59

5.64

1.3

1.62

1.45

nmol/l

0.74

109

687

Glaucoma

256

1637

1.38

5.61

1.3

1.45

1.43

nmol/l

0.08

230

1483

Tubulo-interstitial nephritis, not specified as acute or chronic

164

2.33

5.58

1.2

1.4

1.57

1.49

nmol/l

0.17

141

Noninfective enteritis and colitis

231

1661

1.39

5.53

1.4

1.3

1.49

1.42

nmol/l

0.42

209

1495

Neoplasms

432

1803

1.29

5.51

1.5

1.3

1.44

1.41

nmol/l

0.24

392

1628

Dermatophytosis

426

1.80

5.49

1.2

1.3

1.44

1.49

nmol/l

0.17

378

Gonarthrosis,primary

467

2319

1.27

5.49

1.4

1.3

1.62

1.40

nmol/l

3.81

426

2089

Familial hypercholesterolemia, with ischemic heart disease

237

2.08

5.47

1.2

1.62

1.45

nmol/l

0.54

209

Other diseases of lip and oral mucosa

456

1.76

5.46

1.3

1.2

1.37

1.46

nmol/l

0.34

407

Syphilis

2.91

5.38

1.4

1.2

0.83

1.43

nmol/l

2.31

Sleep disorders

106

655

1.62

5.36

1.4

1.49

1.43

nmol/l

0.20

587

Type1 diabetes, definitions combined, early onset

154

2.34

5.35

1.2

1.4

0.65

1.40

nmol/l

4.01

139

Duodenal ulcer

336

1.89

5.34

1.3

1.2

1.42

1.46

nmol/l

0.11

295

Alcohol withdrawal state with delirium

240

2.06

5.31

1.3

1.28

1.40

nmol/l

0.37

219

111

614

1.61

5.29

1.2

1.39

1.49

nmol/l

0.38

101

559

Other inflammatory liver diseases

188

2.20

5.25

1.8

1.3

1.23

1.41

nmol/l

0.68

168

Speech and linguistic disorders

174

2.22

5.22

1.4

1.2

1.69

1.38

nmol/l

0.94

154

Other CVD

538

1.68

5.19

1.4

1.3

1.31

1.45

nmol/l

0.62

480

Disorders of synovium and tendon

254

1690

1.36

5.15

1.4

1.3

1.51

1.42

nmol/l

0.63

227

1529

Venous thromboembolism

254

1825

1.35

5.14

1.3

1.59

1.41

nmol/l

1.58

231

1651

Exposure to unspecified factor

490

3059

1.24

5.09

1.4

1.3

1.41

1.44

nmol/l

0.20

438

2775

Non-ischemic cardiomyopathy

127

677

1.54

5.07

1.2

1.3

1.52

1.36

nmol/l

0.90

114

608

All influenza (not pneumonia)

474

1.72

5.07

1.4

1.2

1.54

1.44

nmol/l

0.38

424

Dental pulpitis 3, only avohilmo

150

2.15

5.06

1.4

1.55

1.29

nmol/l

0.76

140

Other disorders of bone

100

619

1.62

5.05

1.6

1.3

1.71

1.45

nmol/l

1.12

551

Fracture of foot, except ankle

116

744

1.56

5.05

1.3

1.41

1.44

nmol/l

0.08

104

669

Injuries to the shoulder and upper arm

419

2786

1.26

5.00

1.4

1.3

1.48

1.42

nmol/l

0.58

380

2517

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

125

810

1.53

4.94

1.4

1.38

1.48

nmol/l

0.44

107

727

Follow-up examination after treatment for conditions other than malignant neoplasms

202

943

1.41

4.88

1.3

1.38

1.43

nmol/l

0.21

174

857

COPD related to multimorbidity

189

1130

1.41

4.86

1.4

1.2

1.62

1.40

nmol/l

1.58

172

1018

Transport accidents

238

1559

1.36

4.84

1.3

1.37

1.42

nmol/l

0.32

215

1402

Decubitus ulcer and pressure area

131

2.39

4.82

1.3

1.2

1.21

1.37

nmol/l

0.39

113

Corneal ulcer

566

1.63

4.79

1.5

1.3

1.29

1.44

nmol/l

0.57

505

Dental pulpitis 3

166

2.05

4.78

1.3

1.4

1.48

1.30

nmol/l

0.46

155

Coxibs

156

562

1.48

4.77

1.4

1.3

1.59

1.36

nmol/l

1.47

140

514

Dental caries 1 and operation codes, only avohilmo

135

445

1.53

4.73

1.4

1.3

1.44

1.49

nmol/l

0.18

121

403

Maternal care for known or suspected abnormality of pelvic organs

102

439

1.61

4.73

1.7

1.4

1.53

1.45

nmol/l

0.28

394

Inflammatory disease of uterus

336

1.82

4.72

1.4

1.5

1.71

1.52

nmol/l

0.79

302

Wet age-related macular degeneration

351

1.80

4.71

1.3

1.2

1.26

1.51

nmol/l

1.41

309

Noninfectious colitis NAS

380

1.77

4.71

1.5

1.3

1.50

1.43

nmol/l

0.17

347

Diagnoses used for exclusion with ILD

124

822

1.51

4.68

1.3

1.53

1.44

nmol/l

0.43

107

737

Bacterial pneumonia (organism specified)

203

1341

1.38

4.67

1.3

1.43

1.39

nmol/l

0.25

191

1207

Haemorrhage in early pregnancy

578

1.61

4.67

1.5

1.4

1.51

1.48

nmol/l

0.08

519

Lichen simplex chronicus and prurigo

178

2.15

4.66

1.2

1.3

1.52

1.37

nmol/l

0.44

158

Conjunctivitis (acute, non atopic)

132

885

1.49

4.64

1.3

1.4

1.51

1.45

nmol/l

0.23

115

791

Sarcoidosis

435

1.71

4.60

1.2

1.3

1.61

1.45

nmol/l

0.60

392

Artrosis, including avohilmo

458

2021

1.25

4.58

1.3

1.58

1.37

nmol/l

3.51

412

1819

Other diseases of upper respiratory tract

590

2540

1.21

4.55

1.4

1.3

1.42

nmol/l

0.02

524

2304

Vitamin B12 deficiency anaemia

297

1.86

4.55

1.5

1.3

1.12

1.47

nmol/l

1.60

266

Other diseases of the respiratory system

590

1.60

4.53

1.3

1.50

1.49

nmol/l

0.04

525

Other respiratory disorders and diseases

590

1.60

4.53

1.3

1.50

1.49

nmol/l

0.04

525

Other surgical follow-up care

2.75

4.53

1.2

1.3

1.49

1.40

nmol/l

0.16

Hypotension

453

1.69

4.49

1.4

1.3

1.32

1.42

nmol/l

0.43

404

Trochanteric bursitis

327

1.81

4.49

1.2

1.3

1.70

1.46

nmol/l

0.78

299

Acute suppurative otitis media

121

753

1.50

4.43

1.4

1.40

nmol/l

0.00

108

687

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

168

1195

1.41

4.38

1.5

1.4

1.59

1.44

nmol/l

0.95

159

1074

Acne

223

1.98

4.38

1.7

1.5

1.20

1.45

nmol/l

0.94

207

Benign neoplasm: Ascending colon

404

1.72

4.38

1.3

1.74

1.44

nmol/l

1.21

362

Migraine without aura

449

1.68

4.37

1.4

1.49

1.37

nmol/l

0.45

397

Early onset COPD

119

796

1.50

4.34

1.5

1.3

1.57

1.44

nmol/l

0.54

112

712

Cerebrovascular diseases

362

2055

1.26

4.33

1.3

1.48

1.43

nmol/l

0.38

321

1863

Arthrosis

387

1691

1.26

4.32

1.3

1.57

1.37

nmol/l

2.70

346

1539

ILD medications: azathioprine

413

1.70

4.32

1.4

1.3

1.67

1.37

nmol/l

1.17

362

Conduction disorders

134

760

1.47

4.31

1.3

1.33

1.38

nmol/l

0.25

116

690

Oxicams

137

527

1.48

4.31

1.2

1.3

1.69

1.35

nmol/l

2.31

125

482

Monoamine oxidase A inhibitors

332

1.79

4.29

1.3

1.70

1.43

nmol/l

0.74

293

Preterm labour and delivery

107

702

1.53

4.27

1.4

1.37

1.50

nmol/l

0.73

634

Other enthesopathies

140

973

1.44

4.21

1.4

1.2

1.37

1.43

nmol/l

0.32

126

884

Other arthrosis

272

1493

1.31

4.21

1.4

1.3

1.52

1.37

nmol/l

1.41

241

1354

Benign neoplasm: Ascending colon

409

1.70

4.20

1.3

1.74

1.49

nmol/l

0.91

365

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

826

0.64

4.20

1.4

1.2

1.43

1.44

nmol/l

0.02

751

Use of pramipexole

100

650

1.54

4.19

1.5

1.3

1.58

1.48

nmol/l

0.33

581

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

154

1091

1.42

4.18

1.3

1.54

1.46

nmol/l

0.42

137

977

Diseases of male genital organs

320

1261

1.29

4.16

1.3

1.40

1.38

nmol/l

0.13

283

1148

Supplementary factors related to causes of morbidity and mortality classified elsewhere

145

1018

1.43

4.14

1.3

1.57

1.45

nmol/l

0.77

137

906

Iridocyclitis

109

724

1.51

4.13

1.5

1.3

1.37

1.44

nmol/l

0.29

646

Haemorrhage from respiratory passages

155

1021

1.41

4.12

1.3

1.2

1.60

1.32

nmol/l

1.96

137

929

Soft tissue disorders related to use, overuse and pressure

123

839

1.47

4.10

1.3

1.56

1.44

nmol/l

0.54

115

756

Nonorganic sleeping disorders

551

1.58

4.09

1.3

1.4

1.44

1.40

nmol/l

0.12

497

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

2.89

4.08

1.1

1.2

0.89

1.40

nmol/l

1.03

Dental caries 3 and operation codes, only avohilmo

149

519

1.45

4.05

1.4

1.3

1.47

1.46

nmol/l

0.04

136

472

Bacterial pneumoniae

188

1224

1.36

4.03

1.4

1.3

1.45

1.37

nmol/l

0.46

176

1101

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

869

0.65

4.02

1.4

1.2

1.40

1.42

nmol/l

0.07

790

Abnormalities of gait and mobility

333

1.75

3.98

1.4

1.3

1.49

1.53

nmol/l

0.11

299

Tobacco use

150

2.15

3.97

1.3

1.4

1.51

1.48

nmol/l

0.05

138

Fibroblastic disorders

109

731

1.50

3.96

1.4

1.2

1.28

1.42

nmol/l

0.69

667

Toxic liver disease

3.32

3.93

1.4

1.1

1.33

1.71

nmol/l

0.42

Exposure to other specified factors

363

2744

1.24

3.92

1.4

1.3

1.46

1.42

nmol/l

0.24

326

2484

Strabismus

122

838

1.46

3.90

1.3

1.4

1.52

1.44

nmol/l

0.32

108

748

Vascular diseases of the intestine

2.65

3.90

1.6

1.1

1.48

1.51

nmol/l

0.04

Undetermined asthma, excluding more controls

335

1.74

3.88

1.4

1.2

1.55

1.40

nmol/l

0.40

300

Plantar fascial fibromatosis

255

1.85

3.88

1.3

1.46

1.43

nmol/l

0.08

232

Gastro-oesophageal reflux disease

321

2262

1.26

3.87

1.4

1.3

1.50

1.42

nmol/l

0.54

292

2044

Adenocarcinoma of pancreas

2.80

3.87

1.1

0.89

1.51

nmol/l

1.38

Disorders of psychological development

249

1.83

3.86

1.3

1.4

1.70

1.36

nmol/l

1.32

223

Acute and transient psychotic disorders

367

1.70

3.83

1.2

1.3

1.64

1.40

nmol/l

0.93

327

Hepatic failure, not elsewhere classified

2.45

3.81

1.2

1.4

1.11

1.44

nmol/l

0.65

Paracetamol of NSAID medication

290

1.58

3.81

1.3

1.49

1.30

nmol/l

0.75

264

Azathioprine

429

1.64

3.79

1.4

1.3

1.67

1.37

nmol/l

1.18

378

Ovarian cyst

156

644

1.40

3.76

1.4

1.3

1.39

1.38

nmol/l

0.03

139

577

Otitis externa, unspecified

303

1.76

3.71

1.5

1.3

1.56

1.45

nmol/l

0.28

276

Pain in thoracic spine

440

1.62

3.69

1.3

1.65

1.40

nmol/l

1.07

391

Panniculitis affecting regions of neck and back

103

2.35

3.67

1.5

1.2

1.67

1.26

nmol/l

0.91

Acute and subacute iridocyclitis

615

1.52

3.65

1.5

1.3

1.34

1.46

nmol/l

0.57

551

Diseases of salivary glands

559

1.54

3.65

1.4

1.3

1.91

1.46

nmol/l

2.30

500

Cardiomyopathy, other and unspecified

239

1.85

3.65

1.3

1.2

1.85

1.44

nmol/l

1.16

210

Primary gonarthrosis, bilateral

230

1550

1.30

3.63

1.4

1.3

1.73

1.39

nmol/l

4.13

209

1396

Mouth breathing

208

1583

1.32

3.62

1.3

1.62

1.40

nmol/l

1.57

185

1425

Other diseases of arteries and capillaries

254

1.82

3.62

1.5

1.3

1.56

1.47

nmol/l

0.18

226

Other diseases of blood and blood-forming organs, wide

103

698

1.48

3.60

1.2

1.3

1.40

1.48

nmol/l

0.38

627

Vascular disorders of the intestines

170

2.01

3.59

1.6

1.2

1.49

1.57

nmol/l

0.14

149

Nail disorders

248

1.83

3.57

1.2

1.3

1.58

1.52

nmol/l

0.12

223

Biological medication for rheuma

460

1.59

3.56

1.4

1.3

1.61

1.42

nmol/l

0.78

417

Undetermined asthma

345

1.69

3.53

1.4

1.2

1.55

1.46

nmol/l

0.21

309

Adhesive capsulitis of shoulder

524

1.55

3.53

1.3

1.33

1.50

nmol/l

0.72

475

Superficial injury of thorax

462

1.59

3.50

1.7

1.3

1.32

1.49

nmol/l

0.78

415

Need for other prophylactic measures

165

2.02

3.50

1.3

1.12

1.41

nmol/l

0.89

146

Other disorders of lacrimal gland

148

1078

1.38

3.49

1.4

1.3

1.50

1.48

nmol/l

0.09

130

969

Habitual aborter

3.37

3.48

2.3

1.3

1.65

1.13

nmol/l

0.86

Other specified/unspecified arthritis

125

885

1.42

3.48

1.3

1.71

1.37

nmol/l

2.67

112

804

Deforming dorsopathies

121

852

1.42

3.47

1.3

1.45

nmol/l

0.01

101

755

Excessive attrition of teeth

185

747

1.35

3.46

1.5

1.3

1.36

1.45

nmol/l

0.54

169

680

Medical abortion

246

1036

1.29

3.46

1.3

1.31

1.54

nmol/l

2.68

218

938

Inflammatory bowel disease

149

1089

1.37

3.44

1.5

1.3

1.41

1.47

nmol/l

0.29

133

970

Irritable bowel syndrome

121

855

1.42

3.41

1.8

1.4

1.46

1.43

nmol/l

0.10

113

767

Other arthritis (FG)

143

1040

1.38

3.41

1.3

1.69

1.35

nmol/l

3.12

128

937

Disorders of eyelid, lacrimal system and orbit

397

2570

1.21

3.41

1.3

1.44

1.43

nmol/l

0.04

357

2330

Menorrhagia

150

599

1.39

3.40

1.4

1.3

1.60

1.37

nmol/l

1.68

135

536

Anterior Iridocyclitis

658

1.48

3.40

1.5

1.3

1.32

1.48

nmol/l

0.83

587

Disorders of calcium metabolism

133

2.12

3.39

1.0

1.3

1.56

1.44

nmol/l

0.19

117

D07AA Corticosteroids, weak (group I)

403

1.62

3.38

1.5

1.4

1.75

1.41

nmol/l

1.31

363

Cerebral palsy and other paralytic syndromes

327

1.69

3.38

1.3

1.45

nmol/l

0.01

294

Ulcerative colitis, NAS

428

1.60

3.35

1.4

1.3

1.58

1.41

nmol/l

0.52

386

Benign neoplasm of ovary

444

1.58

3.34

1.2

1.3

1.76

1.40

nmol/l

1.52

399

Other disorders of kidney and ureter

406

1.61

3.32

1.3

1.74

1.49

nmol/l

0.80

363

Benign neoplasm of ovary

445

1.58

3.31

1.2

1.4

1.76

1.45

nmol/l

1.21

399

Chronic periodontitis, complicated

308

1.70

3.26

1.2

1.3

1.44

1.46

nmol/l

0.04

272

Insomnia

471

1.56

3.25

1.3

1.4

1.48

1.43

nmol/l

0.13

422

Pericarditis

2.40

3.23

1.3

1.2

1.66

1.29

nmol/l

0.64

Viral and other specified intestinal infections

562

1.50

3.23

1.5

1.3

1.49

1.41

nmol/l

0.25

520

Chronic sinusitis

201

1552

1.30

3.21

1.5

1.3

1.40

1.44

nmol/l

0.25

178

1395

Functional dyspepsia

116

824

1.41

3.20

1.3

1.45

1.46

nmol/l

0.03

100

740

Oter anti-inflammatory and antirheumatic agents, non-steroids

125

491

1.42

3.20

1.4

1.3

1.60

1.35

nmol/l

1.53

111

451

Injuries to the wrist and hand

486

2979

1.18

3.18

1.3

1.38

1.44

nmol/l

0.70

436

2698

Special screening examination for other diseases and disorders

178

1.92

3.18

1.3

1.2

1.68

1.53

nmol/l

0.25

165

Benign neoplasm: Duodenum

2.76

3.16

1.3

1.1

1.60

nmol/l

0.00

Disorders of mineral metabolism

200

1.86

3.16

1.2

1.3

1.56

1.43

nmol/l

0.26

180

Fracture of shoulder and upper arm

153

1140

1.34

3.15

1.5

1.3

1.30

1.41

nmol/l

0.69

142

1028

Abnormal findings on examination of urine, without diagnosis

124

2.11

3.15

1.8

1.3

1.85

1.37

nmol/l

1.47

111

Transient ischemic attack

230

1498

1.27

3.14

1.3

1.45

1.39

nmol/l

0.34

200

1361

Type of accident

127

920

1.38

3.14

1.3

1.60

1.44

nmol/l

0.97

119

817

Spondylolisthesis/Spondylolysis

556

1.50

3.13

1.3

1.43

1.42

nmol/l

0.04

489

DVT of lower extremities and pulmonary embolism

179

1365

1.31

3.08

1.3

1.66

1.38

nmol/l

2.49

162

1232

Other disorders of ear

454

2551

1.19

3.06

1.3

1.49

1.43

nmol/l

0.63

403

2309

Retention of urine

161

1025

1.33

3.05

1.4

1.3

1.44

1.42

nmol/l

0.06

140

932

Impotence

203

1.84

3.04

1.4

1.2

1.38

1.52

nmol/l

0.30

181

Restless leg syndrome

347

1.62

2.99

1.6

1.3

1.32

1.47

nmol/l

0.53

313

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

483

2673

1.18

2.97

1.4

1.3

1.51

1.42

nmol/l

1.02

436

2417

Operations 2 for CAVS

118

835

1.39

2.96

1.2

1.52

1.44

nmol/l

0.32

112

741

Calcific aortic valvular stenosis, diagnosis (helper)

118

835

1.39

2.96

1.2

1.52

1.44

nmol/l

0.32

112

741

Calcific aortic valvular stenosis

118

836

1.38

2.94

1.2

1.52

1.44

nmol/l

0.32

112

742

Calcific aortic valvular stenosis, operated

118

836

1.38

2.94

1.2

1.52

1.44

nmol/l

0.32

112

742

Disorders of conjunctiva

373

2606

1.20

2.94

1.3

1.49

1.42

nmol/l

0.56

331

2361

Other systemic involvement of connective tissue (FG)

106

749

1.41

2.93

1.3

1.69

1.39

nmol/l

1.76

674

Paralytic ileus and intestinal obstruction

109

780

1.40

2.92

1.4

1.3

1.41

nmol/l

0.01

697

L04AX Other immunosuppressants

252

2029

1.24

2.89

1.3

1.59

1.41

nmol/l

1.82

228

1829

Calcific aortic valvular stenosis, including rheumatic fever

118

838

1.38

2.89

1.2

1.52

1.44

nmol/l

0.33

112

743

Superficial injury of abdomen, lower back and pelvis

437

1.54

2.89

1.7

1.3

1.16

1.47

nmol/l

1.69

395

Toxic effect of carbon monoxide

2.96

2.87

2.1

1.1

1.44

1.43

nmol/l

0.01

Coxarthrosis

244

1322

1.25

2.86

1.3

1.62

1.36

nmol/l

3.14

216

1207

Polyarthrosis

551

1.47

2.86

1.4

1.3

1.69

1.42

nmol/l

1.39

500

Suppurative and unspecified otitis media

156

1048

1.32

2.86

1.3

1.4

1.47

1.43

nmol/l

0.18

135

952

Other joint disorders

441

1984

1.19

2.85

1.4

1.3

1.52

1.38

nmol/l

1.67

392

1810

Enlarged lymph nodes

455

1.52

2.83

1.2

1.3

1.53

1.48

nmol/l

0.14

406

Second line medication for Crohn's disease

258

2089

1.24

2.83

1.3

1.58

1.42

nmol/l

1.70

234

1880

Stroke, excluding SAH

271

1633

1.23

2.82

1.3

1.57

1.40

nmol/l

1.63

236

1490

Car occupant injured in other and unspecified transport accidents

561

1.47

2.82

1.3

1.38

1.44

nmol/l

0.24

502

Salpingitis and oophoritis

488

1.50

2.81

1.4

1.54

1.47

nmol/l

0.18

441

Retinal detachments and breaks

143

1076

1.33

2.81

1.3

1.33

1.47

nmol/l

0.79

127

986

False labour

106

472

1.41

2.81

1.3

1.50

1.42

nmol/l

0.33

426

Conjunctivitis

333

2409

1.21

2.81

1.4

1.3

1.46

1.44

nmol/l

0.12

296

2185

431

1.52

2.80

1.3

1.2

1.52

1.48

nmol/l

0.09

387

Other and unspecified urticaria

554

1.47

2.79

1.7

1.3

1.32

1.45

nmol/l

0.53

498

Diplopia

393

1.56

2.79

1.6

1.3

1.71

1.52

nmol/l

0.58

350

Somatoform disorder

441

1.52

2.78

1.5

1.3

1.98

1.45

nmol/l

1.93

401

Ulcerative colitis

113

823

1.38

2.75

1.4

1.3

1.42

1.45

nmol/l

0.11

100

733

Abnormal involuntary movements

387

1.56

2.74

1.4

1.3

1.70

1.47

nmol/l

0.80

354

Other chronic obstructive pulmonary disease

190

1237

1.28

2.73

1.4

1.2

1.62

1.35

nmol/l

2.26

172

1124

Arthropod-borne viral fevers and viral haemorrhagic fevers

309

1.63

2.73

1.4

1.3

1.56

1.46

nmol/l

0.21

280

Bacterial pneumonia, not elsewhere classified

169

1156

1.30

2.71

1.3

1.46

1.39

nmol/l

0.39

159

1040

Iron deficiency anaemia secondary to blood loss (chronic)

452

1.51

2.71

1.3

1.59

1.47

nmol/l

0.37

408

Other maltreatment syndromes

2.19

2.68

1.2

1.3

1.01

1.38

nmol/l

0.93

Reimbursement for rheumatic diseases

253

2055

1.23

2.66

1.3

1.56

1.43

nmol/l

1.17

230

1846

Heart failure and hypertrophic cardiomyopathy

2.83

2.66

1.4

1.1

1.86

1.51

nmol/l

0.45

Female infertility

122

553

1.36

2.65

1.6

1.4

1.62

1.38

nmol/l

1.45

114

494

Other diseases of anus and rectum

126

940

1.34

2.63

1.3

1.58

1.40

nmol/l

0.80

109

837

Fall on and from stairs and steps

109

796

1.37

2.63

1.4

1.3

1.27

1.46

nmol/l

1.01

715

Ischaemic Stroke, excluding all haemorrhages

249

1529

1.23

2.60

1.2

1.3

1.57

1.39

nmol/l

1.48

220

1391

COPD

198

1295

1.26

2.58

1.4

1.3

1.61

1.36

nmol/l

2.00

179

1176

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

2.38

2.56

1.1

1.2

1.75

1.56

nmol/l

0.21

Stroke, including SAH

290

1773

1.21

2.56

1.3

1.54

1.40

nmol/l

1.16

254

1616

Appendicitis, broad definition

362

2797

1.18

2.56

1.4

1.3

1.54

1.43

nmol/l

1.20

329

2525

Hyperparathyroidism

493

1.47

2.55

1.1

1.3

1.55

1.46

nmol/l

0.32

443

Other orthopaedic follow-up care

171

1.82

2.54

1.3

1.4

1.43

1.39

nmol/l

0.05

150

Rheumatoid arthritis

140

969

1.32

2.54

1.4

1.3

1.62

1.38

nmol/l

1.59

127

878

Diabetic retinopathy

490

2676

1.16

2.53

1.3

1.16

1.47

nmol/l

9.23

402

2466

Thyrotoxicosis, other and/or unspecified

558

1.44

2.53

1.4

1.3

1.35

1.45

nmol/l

0.35

509

Diseases of appendix

364

2809

1.18

2.51

1.4

1.3

1.54

1.43

nmol/l

1.18

331

2537

Other bacterial intestinal infections

501

1.46

2.51

1.7

1.3

1.40

1.48

nmol/l

0.22

452

Methotrexate

412

1.51

2.50

1.4

1.3

1.69

1.45

nmol/l

0.97

365

Fracture of lumbar spine and pelvis

617

1.41

2.49

1.5

1.3

1.17

1.49

nmol/l

2.06

548

Epilepsy

121

904

1.34

2.49

1.4

1.3

1.53

1.32

nmol/l

1.33

106

806

Other disorders of penis

341

1.56

2.48

1.2

1.38

1.40

nmol/l

0.04

307

Herpesviral [herpes simplex] infections

333

1.57

2.48

1.2

1.3

1.47

nmol/l

0.00

301

Premature rupture of membranes

372

1.47

2.48

1.5

1.4

1.47

1.48

nmol/l

0.03

333

Other viral diseases

126

949

1.33

2.47

1.6

1.3

1.37

1.43

nmol/l

0.26

110

851

Ectopic pregnancy

455

1.48

2.44

1.5

1.4

1.43

1.61

nmol/l

0.76

414

Superficial injury of wrist and hand

604

1.41

2.44

1.4

1.3

1.55

1.39

nmol/l

0.59

546

Disorders of parathyroid gland

556

1.42

2.42

1.1

1.3

1.54

1.45

nmol/l

0.36

504

Other and unspecified visual disturbances

257

1.64

2.42

1.2

1.3

1.46

1.53

nmol/l

0.18

233

Other/unspecified synovitis and tenosynovitis

312

1.58

2.40

1.2

1.3

1.61

1.47

nmol/l

0.28

282

Other specified/unspecified spondylopathies

2.37

2.39

1.6

1.1

1.75

1.35

nmol/l

0.79

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.23

2.38

1.2

1.27

1.53

nmol/l

0.37

Injuries to the hip and thigh

194

1424

1.25

2.36

1.3

1.54

1.41

nmol/l

0.82

172

1284

Maltreatment syndromes

125

1.93

2.35

2.0

1.5

1.71

1.36

nmol/l

0.69

114

Valvular heart disease excluding rheumatic fever

205

1206

1.24

2.35

1.3

1.43

1.39

nmol/l

0.23

183

1094

Benign neoplasm: Rectum

559

1.42

2.34

1.4

1.3

1.71

1.46

nmol/l

0.92

502

Spontaneous abortion

170

910

1.27

2.34

1.5

1.4

1.42

1.55

nmol/l

0.86

152

822

Benign neoplasm: Rectum, anus and anal canal

627

1.39

2.32

1.4

1.3

1.68

1.46

nmol/l

0.83

565

Infections with a predominantly sexual mode of transmission

124

943

1.32

2.32

1.5

1.4

1.24

1.47

nmol/l

1.79

103

852

Impingement syndrome of shoulder

114

858

1.33

2.31

1.4

1.2

1.56

1.42

nmol/l

0.62

100

783

Benign neoplasm: Rectum, anus and anal canal

628

1.39

2.30

1.4

1.3

1.68

1.49

nmol/l

0.67

563

Acute appendicitis, no complications

267

2217

1.20

2.30

1.5

1.3

1.50

1.42

nmol/l

0.66

245

1993

Pulmonary heart disease, diseases of pulmonary circulation

129

989

1.31

2.29

1.3

1.73

1.42

nmol/l

2.13

113

890

Missing teeth due to accident, extraction or parodontitis

308

1.56

2.29

1.2

1.31

1.49

nmol/l

0.53

275

Systemic connective tissue disorders

141

1095

1.29

2.28

1.4

1.3

1.66

1.45

nmol/l

1.23

128

982

Superficial injury of forearm

246

1.63

2.27

1.7

1.3

1.89

1.52

nmol/l

0.97

218

Pregnancy with abortive outcome

245

1051

1.22

2.24

1.5

1.3

1.31

1.54

nmol/l

2.89

218

952

Other symptoms and signs involving the digestive system and abdomen

390

1.49

2.24

1.4

1.2

1.53

1.46

nmol/l

0.17

348

Pneumonia due to other infectious organisms, not elsewhere classified

2.11

2.23

1.6

1.2

1.31

1.50

nmol/l

0.35

Disturbances of skin sensation

115

872

1.32

2.23

1.3

1.4

1.40

1.49

nmol/l

0.39

110

779

Abnormal results of function studies

271

1.59

2.23

1.4

1.3

1.53

1.51

nmol/l

0.02

241

Ulcerative colitis (strict definition, all Crohn cases excluded)

440

1.46

2.22

1.3

1.45

1.40

nmol/l

0.14

394

Other arrhythmias

285

1831

1.19

2.20

1.5

1.3

1.60

1.41

nmol/l

1.97

262

1651

Sequelae of cerebrovascular disease

144

988

1.28

2.19

1.2

1.3

1.40

1.42

nmol/l

0.06

129

893

Disorders of lacrimal system

168

1341

1.25

2.19

1.4

1.3

1.49

1.46

nmol/l

0.15

150

1201

Atopic dermatitis, strict definition with reimbursement

121

898

1.31

2.19

1.4

1.47

1.41

nmol/l

0.23

113

804

Other viral diseases, not elsewhere classified

566

1.40

2.17

1.6

1.3

1.32

1.45

nmol/l

0.49

510

Maternal care for known or suspected malpresentation of fetus

309

1.47

2.16

1.9

1.4

1.33

1.49

nmol/l

0.63

278

Appendectomy

300

2447

1.18

2.15

1.5

1.3

1.53

1.43

nmol/l

0.72

270

2207

Benign neoplasm: Rectum

569

1.39

2.14

1.4

1.3

1.71

1.51

nmol/l

0.68

508

Symptoms and signs involving the urinary system

354

2347

1.17

2.12

1.3

1.54

1.41

nmol/l

1.21

311

2127

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

450

2316

1.15

2.12

1.3

1.42

1.45

nmol/l

0.21

400

2094

Non-rheumatic valve diseases

202

1201

1.23

2.12

1.3

1.43

1.38

nmol/l

0.25

180

1090

Acute appendicitis

336

2714

1.17

2.11

1.5

1.3

1.54

1.43

nmol/l

1.04

304

2454

Malignant neoplasm, wide definition for exclusion

450

2317

1.15

2.11

1.3

1.42

1.45

nmol/l

0.21

400

2095

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

450

2317

1.15

2.11

1.3

1.42

1.45

nmol/l

0.21

400

2095

Tumor necrosis factor alpha inhibitors

413

1.46

2.09

1.4

1.3

1.61

1.41

nmol/l

0.74

373

Fall on same level involving ice and snow

244

2036

1.20

2.09

1.4

1.3

1.52

1.40

nmol/l

0.85

224

1833

DVT of lower extremities

589

1.38

2.08

1.4

1.2

1.59

1.47

nmol/l

0.40

526

Benign neoplasm of other and unspecified endocrine glands

389

1.47

2.08

1.4

1.3

1.42

1.49

nmol/l

0.19

349

Other infectious diseases

229

1.62

2.08

1.2

1.3

1.73

1.42

nmol/l

0.65

204

Gonarthrosis, primary, with knee surgery

241

1639

1.20

2.07

1.4

1.3

1.63

1.40

nmol/l

2.47

219

1475

Benign neoplasm: Duodenum

2.19

2.05

1.3

1.2

1.60

1.49

nmol/l

0.13

Cardiac murmurs and other cardiac sounds

204

1.65

2.05

1.3

1.46

1.43

nmol/l

0.05

190

Other systemic involvement of connective tissue

108

823

1.31

2.05

1.3

1.68

1.45

nmol/l

1.14

100

740

Benign neoplasm of other and unspecified endocrine glands

391

1.46

2.03

1.4

1.3

1.42

1.49

nmol/l

0.21

355

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

130

1018

1.28

2.02

1.6

1.3

1.36

1.44

nmol/l

0.43

117

910

Other disorders involving the immune mechanism, not elsewhere classified

2.06

2.01

1.2

1.27

1.45

nmol/l

0.24

Other articular cartilage disorders

2.24

2.01

1.9

1.2

2.30

1.53

nmol/l

0.87

Complications of labour and delivery

229

1056

1.21

2.00

1.4

1.51

1.50

nmol/l

0.05

205

956

Maternal care for known or suspected fetal abnormality and damage

305

1.49

1.98

1.2

1.4

1.38

1.50

nmol/l

0.35

276

Chronic rhinitis, nasopharyngitis and pharyngitis

138

1092

1.27

1.97

1.3

1.47

1.46

nmol/l

0.04

122

985

Thyroiditis, ILD-related definition

288

1.53

1.97

1.3

1.4

1.32

1.49

nmol/l

0.43

255

Maternal care related to the fetus and amniotic cavity and possible delivery problems

159

747

1.25

1.96

1.7

1.3

1.63

1.44

nmol/l

1.37

143

672

Other acute viral hepatitis

2.60

1.93

1.2

1.15

1.47

nmol/l

—

IgA nephropathy (IgA glomerulonephritis)

2.13

1.93

1.3

1.2

1.28

1.57

nmol/l

0.39

Pilonidal cyst

242

1.58

1.92

1.5

1.3

1.54

1.37

nmol/l

0.44

224

Coxarthrosis [arthrosis of hip](FG)

250

1521

1.19

1.92

1.3

1.61

1.33

nmol/l

3.69

222

1378

Mandibular retrognathia

171

0.41

1.90

1.3

1.4

1.25

1.41

nmol/l

—

159

Other noninflammatory disorders of uterus, except cervix

435

1.35

1.89

1.3

1.59

1.38

nmol/l

1.04

392

Enthesopathies of lower limb, excluding foot

721

1.32

1.88

1.3

1.53

1.44

nmol/l

0.34

637

Papilloedema, unspecified

2.33

1.88

1.6

1.2

1.05

1.44

nmol/l

0.95

Achilles tendinitis

324

1.49

1.88

1.4

1.3

1.61

1.39

nmol/l

0.60

286

Carcinoma in situ of colon

2.68

1.87

1.4

1.1

1.11

1.74

nmol/l

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

0.00

1.87

0.0

1.2

—

1.51

—

Leiomyoma of uterus

181

831

1.23

1.86

1.5

1.4

1.66

1.46

nmol/l

1.19

163

750

Toxic effect of contact with venomous animals

100

1.91

1.86

1.5

1.4

1.14

1.40

nmol/l

0.52

Disorders of eyelid in diseases classified elsewhere

2.04

1.85

1.3

1.2

1.84

1.46

nmol/l

0.55

Foreign body in alimentary tract

144

1.74

1.85

1.4

1.60

1.45

nmol/l

0.34

129

Intestinal stricture

123

969

1.27

1.85

1.5

1.3

1.41

1.43

nmol/l

0.05

110

868

Mucosal proctocolitis

383

1.44

1.84

1.4

1.3

1.55

1.39

nmol/l

0.50

345

Hypermobility syndrome

122

1.81

1.84

1.3

1.5

2.10

1.51

nmol/l

0.99

109

Other and unspecified disorders of vitreous body

163

1320

1.23

1.84

1.3

1.67

1.42

nmol/l

1.85

149

1189

Diaphragmatic hernia

148

1193

1.24

1.83

1.5

1.3

1.25

1.43

nmol/l

1.49

132

1072

Acetic acid derivatives and related substances

136

559

1.27

1.83

1.4

1.3

1.64

1.36

nmol/l

1.74

122

511

Inflammatory disorders of breast

137

1.76

1.83

1.2

1.5

1.57

1.46

nmol/l

0.21

125

Progressive vascular leukoencephalopathy

2.14

1.82

1.2

1.22

1.55

nmol/l

0.79

IBD patients in KELA-register

101

778

1.30

1.81

1.4

1.3

1.53

1.44

nmol/l

0.40

696

Pulmonary embolism

114

892

1.28

1.81

1.3

1.73

1.44

nmol/l

1.68

103

802

Immunodeficiency with predominantly antibody defects

2.07

1.81

1.1

1.2

1.82

1.43

nmol/l

0.41

Disorders of ocular muscles, binocular movement, accommodation and refraction

197

1624

1.20

1.81

1.3

1.47

1.45

nmol/l

0.12

177

1462

Other otitis externa (chronic)

168

1.67

1.80

1.2

1.3

1.45

1.43

nmol/l

0.03

150

Pulmonary heart disease

114

893

1.28

1.80

1.3

1.73

1.44

nmol/l

1.71

103

803

Atopic dermatitis, strict definition

115

884

1.28

1.80

1.4

1.48

1.43

nmol/l

0.18

107

799

Sequelae of injuries of lower limb

287

1.50

1.79

1.5

1.3

1.21

1.43

nmol/l

0.80

258

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

513

1.37

1.77

1.4

1.3

1.47

1.41

nmol/l

0.16

457

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

280

2227

1.17

1.77

1.3

1.47

1.42

nmol/l

0.30

249

2015

Diabetic retinopathy, strict definition

259

1944

1.18

1.76

1.3

0.99

1.45

nmol/l

13.56

195

1795

Inflammatory bowel disease, strict (require KELA)

101

782

1.29

1.76

1.4

1.3

1.53

1.44

nmol/l

0.39

700

Delirium, not induced by alcohol and other psychoactive substances

288

1.50

1.75

1.2

1.3

1.40

1.44

nmol/l

0.05

255

Benign neoplasm: Descending colon

193

1.61

1.75

1.8

1.3

1.56

1.46

nmol/l

0.19

169

Crowding of teeth, including avohilmo

162

0.46

1.74

1.3

1.4

1.04

1.49

nmol/l

—

148

Chromosomal abnormalities, not elsewhere classified

2.23

1.73

1.3

1.4

1.83

1.40

nmol/l

0.64

Seropositive rheumatoid arthritis

101

782

1.29

1.73

1.3

1.63

1.39

nmol/l

1.30

703

Otitis media, unspecified

251

1.51

1.72

1.3

1.73

1.35

nmol/l

1.01

230

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

183

1333

1.21

1.72

1.3

1.34

1.44

nmol/l

0.59

167

1207

Other menopausal disorders

479

0.72

1.71

1.7

1.3

1.41

1.37

nmol/l

0.17

426

Bacterial intestinal infections, IBD co-morbidities

542

1.35

1.71

1.7

1.3

1.40

1.51

nmol/l

0.33

482

Leiomyoma of uterus

233

1118

1.19

1.70

1.5

1.3

1.61

1.46

nmol/l

1.00

208

1011

Carcinoma in situ of other and unspecified genital organs

0.00

1.70

0.0

1.5

—

1.19

—

Coagulation defects, purpura and other haemorrhagic conditions

569

1.34

1.69

1.2

1.3

1.55

1.49

nmol/l

0.19

509

Psoriatic and enteropathic arthropathies

357

1.43

1.69

1.4

1.3

1.43

1.41

nmol/l

0.03

320

Conductive and sensorineural hearing loss

366

2222

1.14

1.68

1.3

1.47

1.43

nmol/l

0.27

328

2015

Radial styloid tenosynovitis [de Quervain]

126

1.75

1.68

1.7

1.3

2.03

1.31

nmol/l

1.35

118

Diseases of the myoneural junction and muscle

366

1.43

1.68

1.5

1.3

1.50

1.49

nmol/l

0.02

330

Other degenerative diseases of the nervous system

548

1.30

1.67

1.2

1.09

1.37

nmol/l

2.61

496

Other respiratory diseases principally affecting the interstitium

527

1.35

1.67

1.4

1.3

1.54

1.47

nmol/l

0.23

464

Thyrotoxicosis

736

1.29

1.66

1.3

1.40

1.47

nmol/l

0.22

664

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

392

1.41

1.65

1.6

1.4

1.70

1.50

nmol/l

0.60

353

Glaucoma-related operations

145

0.41

1.64

1.2

1.14

1.50

nmol/l

—

126

Other misadventures during surgical and medical care

2.26

1.64

1.3

1.2

1.20

1.64

nmol/l

0.59

Persons encountering health services in circumstances related to reproduction

201

1617

0.84

1.64

1.4

1.3

1.45

1.43

nmol/l

0.09

189

1452

Organic, including symptomatic, mental disorders

192

1159

1.20

1.62

1.2

1.3

1.31

1.46

nmol/l

1.05

175

1047

Residual foreign body in soft tissue

135

1.71

1.62

1.3

1.2

1.43

1.42

nmol/l

0.02

122

Postmenopausal osteoporosis with pathological fracture

130

0.38

1.62

1.6

1.2

1.48

1.44

nmol/l

—

115

Enterocolitis due to Clostridium difficile

294

1.47

1.62

1.6

1.3

1.26

1.50

nmol/l

0.61

262

Other disorders of eyelid

173

1390

1.20

1.61

1.3

1.39

1.44

nmol/l

0.20

163

1254

Viral warts

270

1.49

1.60

1.4

1.3

1.76

1.46

nmol/l

0.88

241

Meniscus derangement

272

1604

1.16

1.60

1.4

1.3

1.53

1.37

nmol/l

1.53

243

1459

Spondyloarthritis

557

1.33

1.60

1.4

1.3

1.63

1.46

nmol/l

0.61

496

1.84

1.60

1.3

1.2

1.12

1.40

nmol/l

0.49

Noninflammatory disorders of female genital tract

162

668

1.22

1.59

1.5

1.3

1.64

1.37

nmol/l

1.98

148

599

Personal history of allergy to drugs, medicaments and biological substances

2.72

1.58

1.1

1.30

1.43

nmol/l

—

Coeliac disease

337

1.43

1.58

1.5

1.3

1.37

1.47

nmol/l

0.24

305

Macular pucker

396

1.39

1.58

1.2

1.37

1.56

nmol/l

0.55

360

Persons with potential health hazards related to communicable diseases

150

1224

1.22

1.58

1.6

1.4

1.37

1.45

nmol/l

0.48

137

1097

Dislocation, sprain and strain of joints and ligaments at neck level

447

1.37

1.58

1.4

1.3

1.54

1.44

nmol/l

0.20

403

Female infertility, cervigal, vaginal, other or unspecified origin

103

541

1.28

1.57

1.6

1.4

1.60

1.38

nmol/l

1.17

482

Secondary right heart disease

1.86

1.56

1.4

1.1

1.88

1.47

nmol/l

0.68

Carbimazole or st.post thyroidectomy, condition for graves disease

586

1.32

1.56

1.4

1.3

1.21

1.49

nmol/l

1.97

530

Congenital deformities of feet

2.12

1.55

1.3

1.44

1.27

nmol/l

0.18

Open wound of head

227

1913

1.17

1.55

1.4

1.3

1.36

1.39

nmol/l

0.16

210

1722

Other (seronegative) rheumatoid arthritis, wide

570

1.32

1.53

1.3

1.65

1.50

nmol/l

0.50

515

Orthopaedic devices associated with adverse incidents

0.00

1.53

0.0

1.1

—

1.70

—

Carcinoma in situ of other and unspecified genital organs

0.00

1.52

0.0

1.6

—

1.21

—

Burns classified according to extent of body surface involved

2.62

1.52

1.1

1.28

1.58

nmol/l

—

Poor fetal growth

282

1.46

1.51

1.5

1.6

1.52

1.49

nmol/l

0.07

255

Ulcerative colitis (strict definition, require KELA)

537

1.33

1.51

1.4

1.3

1.47

1.44

nmol/l

0.08

478

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

183

0.49

1.50

1.2

0.86

1.53

nmol/l

—

159

Rheumatoid arthritis, including avohilmo

152

1261

1.21

1.49

1.4

1.3

1.62

1.45

nmol/l

1.05

139

1135

Propionic acid derivatives

142

582

1.23

1.49

1.4

1.3

1.45

1.34

nmol/l

0.52

127

532

Sequelae of injuries, of poisoning and of other consequences of external causes

103

820

1.26

1.49

1.6

1.3

1.24

1.47

nmol/l

1.69

738

Benign paroxysmal vertigo

112

901

1.25

1.48

1.3

1.51

1.46

nmol/l

0.19

103

805

Subjective visual disturbances

759

1.27

1.47

1.3

1.46

1.48

nmol/l

0.07

684

COPD, hospital admission 2, with asthma infections

130

906

1.23

1.46

1.4

1.2

1.67

1.42

nmol/l

1.43

118

814

Primary open-angle glaucoma, strict

741

1.27

1.45

1.2

1.3

1.32

1.45

nmol/l

0.65

662

Myocardial infarction, unclassifiable

591

1.28

1.44

1.2

1.39

1.44

nmol/l

0.17

527

150

1173

1.20

1.44

1.3

1.2

1.38

1.44

nmol/l

0.33

129

1063

Single delivery by caesarean section

300

1.33

1.42

1.7

1.3

1.47

1.44

nmol/l

0.09

262

Follicular cysts of skin and subcutaneous tissue

596

1.29

1.41

1.3

1.60

1.47

nmol/l

0.38

539

Other extrapyramidal and movement disorders in other diseases

693

1.27

1.41

1.5

1.3

1.40

1.47

nmol/l

0.24

619

Malignant neoplasm of rectosigmoid junction

2.27

1.40

1.6

1.1

1.46

1.70

nmol/l

—

Fitting and adjustment of other devices

133

1021

1.21

1.39

1.2

1.3

1.52

1.42

nmol/l

0.47

120

930

Schizotypal disorder

1.95

1.38

1.2

1.69

1.31

nmol/l

1.02

Transient global amnesia

262

0.57

1.37

1.1

1.3

1.45

1.51

nmol/l

0.12

236

Obstructed labour due to maternal pelvic abnormality

407

1.35

1.37

1.5

1.4

1.69

1.51

nmol/l

0.53

371

Abnormal findings on diagnostic imaging of other body structures

373

1.37

1.3

1.45

1.48

nmol/l

0.07

341

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

590

1.29

1.37

1.4

1.3

1.44

nmol/l

0.00

526

Long labour

537

1.29

1.36

1.2

1.5

1.35

1.52

nmol/l

0.94

485

Polypectomy (DHB20)

223

1.49

1.36

1.5

1.3

1.48

1.39

nmol/l

0.19

204

Donors of organs and tissues

0.00

1.35

0.0

1.1

—

1.25

—

Open wound of wrist and hand

196

1665

1.17

1.34

1.3

1.38

1.42

nmol/l

0.23

178

1502

Disorders of breast

169

1327

1.18

1.33

1.5

1.4

1.58

1.49

nmol/l

0.58

154

1199

Sensorineural hearing loss

342

2129

1.13

1.33

1.3

1.43

nmol/l

0.03

305

1929

Lateral epicondylitis

401

1.35

1.33

1.3

1.44

1.49

nmol/l

0.19

361

Other chronic obstructive pulmonary disease, including avohilmo

230

1660

1.15

1.33

1.4

1.3

1.62

1.39

nmol/l

1.95

209

1503

Oral leukoplakia and related diseases, including avohilmo

283

1.42

1.31

1.4

1.3

1.23

1.48

nmol/l

0.67

254

Diseases of middle ear and mastoid

241

1722

1.15

1.30

1.3

1.4

1.50

1.45

nmol/l

0.29

207

1555

Nonsuppurative otitis media

551

1.27

1.30

1.3

1.4

1.47

1.41

nmol/l

0.20

504

Symptoms and signs involving the skin and subcutaneous tissue

292

2572

1.13

1.29

1.3

1.49

1.43

nmol/l

0.34

269

2322

Other abnormal uterine and vaginal bleeding

460

1.27

1.29

1.5

1.3

1.60

1.37

nmol/l

1.05

413

COPD, hospital admissions

188

1364

1.17

1.28

1.4

1.2

1.64

1.40

nmol/l

1.78

170

1239

Other hearing loss

100

796

1.24

1.28

1.3

1.44

nmol/l

0.01

716

COPD, early/later onset

190

1377

1.17

1.28

1.4

1.2

1.62

1.40

nmol/l

1.66

172

1249

Congenital malformations, deformations and chromosomal abnormalities

252

2119

1.14

1.27

1.3

1.4

1.53

1.42

nmol/l

0.83

229

1908

Other inflammation of eyelid

379

1.35

1.26

1.6

1.3

1.88

1.45

nmol/l

1.37

344

Seborrhoeic keratosis

642

1.26

1.2

1.3

1.51

1.44

nmol/l

0.24

575

Benign neoplasm: Descending colon

211

1.48

1.25

1.8

1.3

1.56

1.51

nmol/l

0.09

184

Ankylosing hyperostosis [Forestier]

2.24

1.25

1.0

1.1

2.13

1.55

nmol/l

—

Primary open-angle glaucoma

113

907

1.22

1.24

1.2

1.3

1.37

1.45

nmol/l

0.32

103

815

Endometriosis

128

631

1.21

1.24

1.4

1.64

1.38

nmol/l

1.63

113

565

Anti-inflammatory and antirheumatic products, non-steroids

139

582

1.20

1.23

1.3

1.43

1.34

nmol/l

0.43

125

532

Disorders of globe

1.92

1.23

1.0

1.2

1.70

1.45

nmol/l

0.32

Dementia, including avohilmo

156

911

1.18

1.22

1.3

1.2

1.20

1.44

nmol/l

2.76

142

819

Suggestive for eosinophilic asthma

271

1.41

1.21

1.7

1.3

1.18

1.40

nmol/l

0.72

244

Perforation of tympanic membrane

280

1.40

1.20

1.4

1.3

1.71

1.49

nmol/l

0.59

254

Car occupant injured in noncollision transport accident

101

1.69

1.20

1.4

0.94

1.50

nmol/l

1.99

Dental caries 2 and operation codes, only avohilmo

272

1906

0.88

1.20

1.6

1.3

1.30

1.45

nmol/l

1.71

241

1730

Traumatic subarachnoid haemorrhage

1.84

1.19

1.6

1.2

0.98

1.33

nmol/l

0.71

COPD (mode)

128

849

1.20

1.19

1.4

1.2

1.68

1.37

nmol/l

1.65

114

769

Phlebitis and thrombophlebitis (not including DVT)

737

1.24

1.19

1.3

1.54

1.47

nmol/l

0.22

661

Complications predominantly related to the puerperium

737

1.24

1.19

1.2

1.5

1.68

1.48

nmol/l

0.84

666

Other pulmonary heart/vessel disease

109

1.66

1.19

1.4

1.1

2.10

1.43

nmol/l

1.08

Pregnancy, childbirth and the puerperium

405

1.24

1.19

1.5

1.3

1.39

1.52

nmol/l

0.53

359

Melanocytic naevi, other sites/unspecified

222

1.45

1.18

1.4

1.61

1.49

nmol/l

0.20

196

Other strabismus

656

1.25

1.17

1.3

1.4

1.53

1.41

nmol/l

0.47

591

Pyoderma

2.01

1.17

1.6

1.1

1.08

1.46

nmol/l

—

Acute poliomyelitis

0.00

1.16

0.0

1.1

—

1.52

—

Injuries to the neck

731

1.23

1.15

1.4

1.3

1.38

1.46

nmol/l

0.25

657

Effects of foreign body entering through natural orifice

107

885

1.21

1.15

1.4

1.3

1.56

1.42

nmol/l

0.75

795

Unspecified fall

192

1656

1.15

1.14

1.3

1.33

1.41

nmol/l

0.49

173

1490

Fissure and fistula of anal and rectal regions

101

832

1.22

1.14

1.3

1.54

1.42

nmol/l

0.56

740

Other diseases of pleura

180

1380

1.16

1.13

1.4

1.3

1.48

1.40

nmol/l

0.45

162

1255

Other embolism and thrombosis

396

1.32

1.12

1.1

1.3

1.58

1.50

nmol/l

0.19

356

Dermatitis due to ingested food

1.90

1.11

1.6

1.4

0.82

1.18

nmol/l

0.92

Burns and corrosions of multiple and unspecified body regions

1.83

1.09

1.2

1.22

1.49

nmol/l

0.49

Crohn disease

398

1.31

1.09

1.7

1.3

1.53

1.42

nmol/l

0.29

356

Discitis, unspecified

1.96

1.09

1.4

1.1

1.81

1.45

nmol/l

—

Delivery, wide proxy

112

494

1.21

1.09

1.4

1.3

1.49

1.50

nmol/l

0.03

102

434

Stenosis and insufficiency of lacrimal passages

256

0.62

1.09

1.1

1.3

1.33

1.48

nmol/l

0.34

232

Non-small cell lung cancer, adenocarcinoma, helper endpoint

163

0.55

1.08

1.2

0.86

1.44

nmol/l

—

142

Non-small cell lung cancer, adenocarcinoma

163

0.55

1.08

1.2

0.86

1.44

nmol/l

—

142

Migraine without aura and triptan purchases

425

1.30

1.08

1.4

1.5

1.46

1.43

nmol/l

0.07

376

Melanocytic naevi, other sites/unspecified

227

1.41

1.07

1.4

1.61

1.49

nmol/l

0.20

204

Inguinal hernia

232

1767

0.88

1.07

1.4

1.3

1.31

1.41

nmol/l

0.86

201

1598

Bulimia nervosa (incl. atypical)

1.76

1.07

1.3

1.5

2.13

1.49

nmol/l

0.91

Superficial injury of shoulder and upper arm

330

1.34

1.06

1.3

1.2

2.02

1.47

nmol/l

1.56

296

Other or unspecified ileus, impaction or obstruction

550

1.26

1.06

1.4

1.3

1.45

nmol/l

0.01

487

Rosacea

314

1.34

1.04

1.6

1.3

1.59

1.49

nmol/l

0.25

284

Intentional self-harm by sharp object

1.84

1.03

1.2

1.3

1.53

1.39

nmol/l

0.13

Amputation of thigh

1.84

1.03

1.4

1.1

2.14

1.57

nmol/l

0.81

Agranulocytosis

315

1.34

1.02

1.2

1.3

1.47

1.52

nmol/l

0.14

284

Seropositive rheumatoid arthritis, wide

100

834

1.20

1.02

1.4

1.3

1.63

1.45

nmol/l

0.85

747

Leisure time condition

527

1.25

1.01

1.5

1.3

1.72

1.46

nmol/l

1.08

477

Dislocation, sprain and strain of joints and ligaments of knee

266

2214

1.12

1.01

1.3

1.49

1.44

nmol/l

0.36

239

2004

Pollen allergy

495

1.26

1.01

1.4

1.49

1.35

nmol/l

0.39

445

Sequelae of injuries of neck and trunk

1.66

1.00

2.1

1.3

1.24

1.50

nmol/l

0.45

Non-allergic asthma

256

1.37

1.00

1.5

1.3

1.45

1.43

nmol/l

0.05

232

Alzheimer disease

561

0.79

1.00

1.1

1.2

1.02

1.46

nmol/l

4.21

503

Malignant neoplasm of ovary

110

0.45

1.00

1.8

1.4

1.49

nmol/l

—

Benign neoplasm: Colon, unspecified

796

1.20

0.99

1.3

1.40

1.45

nmol/l

0.15

721

Disorders of vestibular function (Vertigo)

181

1577

1.14

0.99

1.4

1.3

1.50

1.45

nmol/l

0.27

164

1421

Other chondrocalcinosis

0.00

0.98

0.0

1.1

—

1.64

—

Medicines for HER+ breast cancer

999

0.83

0.98

1.5

1.3

1.59

1.48

nmol/l

0.42

896

Impacted cerumen

275

1.35

0.97

1.2

1.3

1.47

1.48

nmol/l

0.01

247

Pyothorax

116

1.56

0.96

1.2

1.55

1.42

nmol/l

0.18

104

Postpartum care and examination

218

1.32

0.96

1.6

1.5

1.47

1.50

nmol/l

0.06

192

Contact with machinery

398

1.28

0.96

1.2

1.3

1.45

1.44

nmol/l

0.03

356

Secondary and unspecified malignant neoplasm of lymph nodes

250

1.36

0.95

1.3

1.19

1.41

nmol/l

0.73

222

Other/unspecified seropositive rheumatoid arthritis

823

1.19

0.95

1.4

1.3

1.63

1.45

nmol/l

0.81

739

Dermatopolymyositis

1.90

0.94

2.1

1.1

1.92

1.51

nmol/l

—

Obstructive hydrocephalus

1.90

0.94

1.1

1.50

nmol/l

—

Internal derangement of knee

163

1423

1.14

0.94

1.5

1.3

1.46

1.36

nmol/l

0.53

144

1294

Vascular dementia (mixed)

2.24

0.93

1.5

1.1

1.78

1.70

nmol/l

—

Benign neoplasm: Colon, unspecified

806

1.19

0.93

1.3

1.40

1.46

nmol/l

0.20

717

Malignant neoplasm of breast, HER-positive

941

0.83

0.93

1.4

1.3

1.58

1.48

nmol/l

0.38

847

Neuromuscular dysfunction of bladder

269

1.34

0.92

1.3

1.14

1.53

nmol/l

1.42

244

Volvulus

1.83

0.92

1.2

1.1

1.29

1.50

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

817

1.19

0.92

1.4

1.3

1.61

1.45

nmol/l

0.69

734

Localized scleroderma [morphea]

2.16

0.91

1.2

1.12

1.44

nmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

2.15

0.91

1.3

1.2

1.58

nmol/l

—

Malignant neoplasm of breast, HER2-negative

127

1082

0.86

0.91

1.5

1.3

1.59

1.48

nmol/l

0.50

114

977

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

179

1652

0.88

0.91

1.4

1.3

1.46

1.49

nmol/l

0.14

163

1487

Budesonide

375

1.28

0.90

1.3

1.48

1.38

nmol/l

0.26

331

Allergic conjunctivitis

219

1928

1.12

0.90

1.4

1.3

1.43

1.46

nmol/l

0.16

195

1737

Artificial joint operation, meniscal resection

421

2582

1.09

0.89

1.4

1.3

1.57

1.41

nmol/l

2.04

383

2328

Orchitis and epididymitis

314

1.31

0.89

1.3

1.2

1.38

1.42

nmol/l

0.12

285

Other benign neoplasms of skin

141

1228

1.15

0.89

1.3

1.49

1.44

nmol/l

0.23

128

1102

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

208

1827

1.12

0.88

1.3

1.44

1.45

nmol/l

0.09

185

1647

Benign neoplasm: Liver/bile ducts

1.79

0.88

1.1

1.6

1.81

1.49

nmol/l

—

Nontoxic multinodular goitre

520

1.23

0.88

1.3

1.32

1.43

nmol/l

0.37

478

Other benign neoplasms of uterus

130

0.54

0.87

1.6

1.2

1.25

1.47

nmol/l

—

113

Other benign neoplasms of uterus

131

0.53

0.87

1.6

1.2

1.25

1.34

nmol/l

—

113

Actinic keratosis

127

1044

1.16

0.86

1.3

1.2

1.40

1.46

nmol/l

0.25

107

944

Carcinoma in situ of other and unspecified digestive organs

1.73

0.86

1.4

1.2

1.32

1.71

nmol/l

0.58

Guillain-Barre syndrome

1.83

0.86

1.5

1.2

0.93

1.48

nmol/l

—

Deep bite

262

0.70

0.86

1.4

1.3

1.70

1.40

nmol/l

0.61

241

Exclusion endpoint for clefts

1.83

0.86

1.3

1.2

2.13

1.39

nmol/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

317

1.30

0.85

1.1

1.3

1.59

1.46

nmol/l

0.37

285

Alzheimer’s disease, wide definition

459

0.78

0.85

1.1

1.2

1.00

1.46

nmol/l

3.37

410

Evidence of alcohol involvement determined by blood alcohol level

1.79

0.84

1.1

1.2

1.24

1.37

nmol/l

—

Hallux valgus (acquired)

817

0.85

0.84

1.4

1.3

1.33

1.44

nmol/l

0.52

738

Other and unspecified rosacea

239

1.34

0.84

1.5

1.3

1.66

1.47

nmol/l

0.43

218

Family history of certain disabilities and chronic diseases leading to disablement

111

0.54

0.83

1.3

1.2

1.22

1.43

nmol/l

—

100

Palmar fascial fibromatosis [Dupuytren]

479

1.23

0.83

1.4

1.2

1.12

1.42

nmol/l

1.43

431

Carcinoma in situ of other and unspecified digestive organs

1.70

0.82

1.4

1.2

1.32

1.49

nmol/l

0.21

Benign neoplasm: other/unspecified salivary gland

1.70

0.82

1.1

1.2

2.24

1.59

nmol/l

0.89

Other obstructive and reflux uropathy

105

1.53

0.81

1.5

1.4

1.90

1.58

nmol/l

0.43

Primary coxarthrosis, bilateral

104

893

1.17

0.81

1.3

1.70

1.39

nmol/l

1.81

807

Anogenital herpesviral [herpes simplex] infection

155

1.42

0.81

1.7

1.3

1.63

1.50

nmol/l

0.18

142

Sexual dysfunction

1.71

0.81

1.1

1.2

1.13

1.24

nmol/l

—

Erosion of teeth, including avohilmo

587

1.20

0.80

1.6

1.3

1.20

1.45

nmol/l

1.50

531

Seropositive rheumatoid arthritis, strict definition

445

1.24

0.80

1.3

1.83

1.49

nmol/l

1.08

406

Contraceptive management

148

1179

0.88

0.79

1.6

1.4

1.54

1.43

nmol/l

0.65

136

1063

Degenerative diseases of the nervous system

706

0.84

0.79

1.2

1.02

1.46

nmol/l

5.50

635

Immunodeficiencies

139

1.44

0.79

1.1

1.4

1.81

1.39

nmol/l

0.59

125

Abdominal aortic aneurysm (AAA)

231

1.33

0.79

1.1

1.2

1.67

1.36

nmol/l

0.76

199

5-aminosalicylic acid

683

1.19

0.79

1.3

1.42

1.38

nmol/l

0.13

601

Communicating hydrocephalus

1.67

0.79

1.4

1.2

1.08

1.55

nmol/l

—

Blood alcohol or alcohol intoxication level

1.67

0.79

1.1

1.4

1.27

1.31

nmol/l

0.05

L01XX Other antineoplastic agents

150

0.60

0.78

1.3

1.2

1.35

1.34

nmol/l

—

130

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

111

961

1.16

0.78

1.4

1.46

1.47

nmol/l

0.04

104

867

Other disorders of conjunctiva

429

1.24

0.78

1.2

1.3

1.67

1.50

nmol/l

0.41

386

Spondylopathies (FG)

429

1.24

0.78

1.2

1.3

1.70

1.38

nmol/l

1.23

386

Tinnitus

795

1.17

0.78

1.6

1.3

1.58

1.46

nmol/l

0.47

713

Other benign neoplasms of skin

141

1219

1.14

0.77

1.3

1.49

1.44

nmol/l

0.20

128

1101

Later onset COPD

666

0.84

0.77

1.2

1.72

1.41

nmol/l

1.15

593

L02BG Aromatase inhibitors

792

0.83

0.77

1.5

1.3

1.47

1.46

nmol/l

0.02

711

Blepharochalasis

104

898

1.16

0.77

1.4

1.3

1.38

1.46

nmol/l

0.31

805

Suppurative and necrotic conditions of lower respiratory tract

157

1.41

0.76

1.2

1.59

1.41

nmol/l

0.33

144

Degenerative macular diseases

296

1.29

0.76

1.2

1.44

1.53

nmol/l

0.18

268

Other hammer toe(s) (acquired)

464

0.79

0.76

1.4

1.3

1.37

1.40

nmol/l

0.07

425

Dentofacial anomalies [including malocclusion]

788

1.17

0.76

1.4

1.3

1.65

1.48

nmol/l

0.81

709

Other skin changes

503

1.21

0.76

1.2

1.3

1.71

1.47

nmol/l

0.91

450

Other congenital malformations of skin

1.52

0.75

1.7

1.4

1.48

1.40

nmol/l

0.13

Benign neoplasm: Liver

1.71

0.75

1.1

1.5

1.53

1.44

nmol/l

—

Other renal tubulo-interstitial diseases

1.70

0.75

1.1

1.4

1.73

1.55

nmol/l

—

Hereditary corneal dystrophies

1.61

0.75

1.6

1.2

1.67

1.32

nmol/l

0.51

Infectious mononucleosis

192

1.36

0.75

1.4

1.3

1.53

1.46

nmol/l

0.09

177

Other and unspecified vasculitis limited to skin

1.67

0.74

1.3

1.1

1.31

1.55

nmol/l

—

Venous complications and haemorrhoids in pregnancy

2.09

0.74

2.4

2.0

1.66

1.38

nmol/l

—

Procreative management

929

0.86

0.74

1.4

1.3

1.43

nmol/l

0.01

836

Measles

1.86

0.74

1.1

1.8

1.23

1.42

nmol/l

—

Fourth [trochlear] nerve palsy

1.64

0.73

1.1

1.14

1.56

nmol/l

—

Melanocytic naevi of upper limb, including shoulder

1.64

0.73

1.7

1.5

1.33

1.34

nmol/l

—

Skin changes due to chronic exposure to nonionizing radiation

130

1083

1.14

0.73

1.3

1.41

1.46

nmol/l

0.17

110

981

Amiodarone users

334

1.26

0.73

1.3

1.2

1.97

1.47

nmol/l

1.21

296

Dementia in other diseases classified elsewhere

107

0.56

0.72

1.0

1.2

0.96

1.42

nmol/l

—

Carrier of infectious disease

1.67

0.72

1.2

1.42

1.49

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.55

0.72

1.0

1.2

1.58

1.45

nmol/l

0.14

Complications of internal orthopaedic prosthetic devices, implants and grafts

654

1.18

0.71

1.6

1.2

1.59

1.44

nmol/l

0.56

592

Disorders of tooth development and eruption

1.49

0.70

1.3

1.43

1.29

nmol/l

0.29

Focal epilepsy, mode (most common among epilepsy diagnosis)

572

1.19

0.70

1.5

1.3

1.57

1.47

nmol/l

0.31

514

Focal epilepsy

655

1.18

0.70

1.5

1.3

1.62

1.46

nmol/l

0.61

586

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.72

0.70

2.3

1.5

1.20

1.21

nmol/l

—

Benign neoplasm: Liver

1.56

0.70

1.1

1.5

1.53

1.52

nmol/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.53

0.69

1.0

1.2

2.00

1.40

nmol/l

1.56

Benign neoplasm of other and unspecified intrathoracic organs

1.86

0.68

1.4

1.1

1.26

1.50

nmol/l

—

Benign neoplasm: Liver/bile ducts

1.65

0.68

1.1

1.5

1.81

1.57

nmol/l

—

Benign neoplasm: other/unspecified salivary gland

1.60

0.68

1.1

1.2

2.24

1.43

nmol/l

1.17

Injury of nerves and spinal cord at neck level

1.53

0.68

1.2

0.87

1.56

nmol/l

—

Chorioretinal inflammation

1.60

0.68

1.3

1.4

2.01

1.46

nmol/l

0.89

Vasculitis limited to skin, not elsewhere classified

1.53

0.68

1.3

1.1

1.31

1.47

nmol/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

118

0.59

0.68

1.3

1.4

1.20

1.42

nmol/l

—

106

Adjustment and management of implanted device

538

1.19

0.67

1.5

1.3

1.45

1.43

nmol/l

0.05

480

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

120

0.58

0.67

1.3

1.4

1.20

1.37

nmol/l

—

106

Postmenopausal bleeding

451

1.16

0.67

1.5

1.3

1.57

1.38

nmol/l

0.77

408

Other specified disorders of kidney and ureter

1.52

0.66

1.4

1.2

2.30

1.56

nmol/l

0.95

Other bursitis of hip

1.60

0.65

1.0

1.55

1.35

nmol/l

—

Secondary parkinsonism

1.62

0.65

1.2

1.1

1.70

1.45

nmol/l

—

Wide developmental disorders

1.62

0.65

1.4

1.79

1.09

nmol/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

226

2029

1.09

0.64

1.3

1.46

1.42

nmol/l

0.26

205

1834

Abnormal serum enzyme levels

128

1125

1.12

0.64

1.4

1.3

1.37

1.42

nmol/l

0.25

116

1020

Crohn disease (strict definition, all UC cases excluded)

146

1.37

0.63

1.5

1.4

1.74

1.46

nmol/l

0.59

134

Peritonsillar abscess

746

1.15

0.63

1.6

1.4

1.43

1.47

nmol/l

0.11

671

Extrapyramidal and movement disorders

133

1189

1.12

0.63

1.4

1.3

1.55

1.42

nmol/l

0.71

121

1072

Retinal detachment with retinal break

387

1.22

0.62

1.3

1.63

1.58

nmol/l

0.09

350

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

758

0.87

0.62

1.5

1.3

1.59

1.48

nmol/l

0.39

678

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

171

1293

0.91

0.62

1.3

1.40

1.45

nmol/l

0.21

153

1173

Benign neoplasm: Skin of eyelid, including canthus

461

1.19

0.61

1.3

1.39

1.44

nmol/l

0.16

414

Respiratory insufficiency

208

1.30

0.61

1.4

1.2

1.68

1.48

nmol/l

0.43

184

Deviated nasal septum

149

1343

1.11

0.61

1.3

1.48

1.42

nmol/l

0.28

133

1220

Bitten or struck by other mammals

307

1.24

0.60

1.4

1.3

1.39

1.48

nmol/l

0.23

275

Exposure to smoke, fire and flames

1.51

0.60

1.5

1.2

1.87

1.44

nmol/l

0.64

Burn and corrosion of trunk

1.51

0.60

1.3

1.2

1.41

1.45

nmol/l

0.05

Atrophic disorders of skin

362

1.22

0.60

1.4

1.3

1.42

1.49

nmol/l

0.14

325

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

227

1.28

0.59

1.2

1.3

1.87

1.44

nmol/l

1.15

202

Other spirochaetal diseases

844

0.86

0.59

1.3

1.31

1.51

nmol/l

0.97

759

Viral pneumonia (known virus, not influenza)

1.54

0.59

1.9

1.2

1.39

1.60

nmol/l

—

Abrasion of teeth

104

675

1.13

0.59

1.4

1.3

1.45

1.46

nmol/l

0.01

609

Malignant neoplasm of breast

136

1091

0.90

0.59

1.5

1.3

1.57

1.48

nmol/l

0.41

123

984

Benign neoplasm of middle ear and respiratory system

265

0.75

0.58

1.1

1.3

1.27

1.49

nmol/l

1.07

237

Malignant neoplasm

422

2358

1.06

0.57

1.4

1.3

1.45

1.43

nmol/l

0.09

375

2137

Beningn neoplasm: Meninges, unspecified

1.67

0.57

1.2

1.1

1.53

1.46

nmol/l

—

Peroneal tendinitis

1.67

0.57

1.2

1.1

0.99

1.59

nmol/l

—

Anankastic personality disorder

1.43

0.56

1.4

1.5

1.64

1.51

nmol/l

0.20

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.58

0.56

1.4

1.5

2.02

1.45

nmol/l

—

Major anomalies of jaw size

1.51

0.56

1.4

1.5

1.78

1.50

nmol/l

0.38

Disorders of synovium and tendon in diseases classified elsewhere

1.46

0.56

1.1

1.20

1.36

nmol/l

—

Serous carcinoma of ovary

0.57

0.56

1.4

2.02

1.47

nmol/l

—

Atopic dermatitis

213

1675

1.09

0.55

1.4

1.3

1.44

1.43

nmol/l

0.07

200

1512

Cysts of oral region, not elsewhere classified

124

1.37

0.55

1.2

1.3

1.44

1.39

nmol/l

0.09

110

Allergic contact dermatitis

357

1.21

0.55

1.3

1.4

1.39

1.40

nmol/l

0.02

320

Other juvenile arthritis

1.47

0.54

1.8

1.3

1.26

1.59

nmol/l

0.47

Benign neoplasm: Skin of eyelid, including canthus

468

1.18

0.54

1.3

1.39

1.52

nmol/l

0.46

420

Lyme disease

836

0.87

0.54

1.3

1.31

1.51

nmol/l

1.02

751

Haemorrhoids and perianal venous thrombosis

106

946

1.12

0.53

1.4

1.3

1.52

1.40

nmol/l

0.48

851

Benign neoplasm of brain and other parts of central nervous system

193

0.72

0.53

1.1

1.3

1.59

1.42

nmol/l

0.25

173

Ménière disease

283

0.78

0.53

1.4

1.3

1.40

1.50

nmol/l

0.19

255

Melanocytic naevi of upper limb, including shoulder

1.46

0.53

1.7

1.5

1.33

1.42

nmol/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

164

1237

0.91

0.53

1.3

1.39

1.44

nmol/l

0.29

147

1123

Lichen ruber planus, wide definition including periferal and oral lichen planus

656

1.14

0.52

1.2

1.3

1.61

1.49

nmol/l

0.37

596

Secondary parkinsonism+Parkinsonism in other disease

1.52

0.52

1.2

1.1

1.70

1.44

nmol/l

—

Divergent concomitant strabismus

214

1.26

0.52

1.5

1.4

1.34

1.45

nmol/l

0.17

192

Primary_lymphoid and hematopoietic malignant neoplasms

769

1.13

0.52

1.4

1.3

1.26

1.44

nmol/l

0.93

695

Bacterial, viral and other infectious agents

287

1.22

0.51

1.4

1.3

1.45

1.43

nmol/l

0.04

262

Carcinoma in situ of breast, intraductal

197

1.27

0.51

1.2

1.4

1.63

1.50

nmol/l

0.26

177

Ulcerative rectosigmoiditis

242

1.24

0.51

1.2

1.3

1.38

1.50

nmol/l

0.34

218

Other noninfective disorders of lymphatic vessels and lymph nodes

1.42

0.50

1.1

1.2

1.43

1.44

nmol/l

0.01

Other localized connective tissue disorders

1.47

0.50

1.2

1.12

1.27

nmol/l

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

179

0.72

0.50

1.2

1.4

1.37

1.45

nmol/l

0.10

162

Benign neoplasm of brain and other parts of central nervous system

190

0.74

0.49

1.1

1.3

1.59

1.41

nmol/l

0.27

167

Carcinoma in situ, bladder

1.43

0.49

1.3

1.2

1.22

1.55

nmol/l

0.66

Other malignant neoplasms of skin (=non-melanoma skin cancer)

173

1482

0.92

0.49

1.3

1.41

1.43

nmol/l

0.11

155

1340

Abnormal findings on diagnostic imaging of lung

184

1655

1.08

0.49

1.2

1.3

1.50

1.40

nmol/l

0.63

168

1496

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

334

0.81

0.49

1.3

1.18

1.47

nmol/l

0.96

294

Diseases of inner ear

206

1872

1.08

0.48

1.3

1.49

1.43

nmol/l

0.34

185

1687

Pneumocystosis

1.53

0.48

1.1

1.2

1.18

1.77

nmol/l

—

Autism spe

1.53

0.48

1.1

1.4

1.77

1.27

nmol/l

—

Generalized epilepsy

119

1.35

0.48

1.0

1.4

1.94

1.44

nmol/l

1.48

110

Injury of muscle and tendon at shoulder and upper arm level

151

1385

1.09

0.48

1.5

1.3

1.61

1.40

nmol/l

1.39

135

1258

Motorcycle rider injured in other and unspecified transport accidents

172

1.28

0.48

1.3

1.4

1.67

1.40

nmol/l

0.41

160

Primary_lymphoid and hematopoietic malignant neoplasms

775

1.12

0.48

1.4

1.3

1.26

1.47

nmol/l

1.20

692

Tonsillectomy and adenotomy

228

1479

1.07

0.48

1.4

1.44

1.46

nmol/l

0.08

207

1332

Left bundle-branch block

199

1.26

0.48

1.6

1.3

1.46

1.44

nmol/l

0.05

174

Embedded teeth, including avohilmo

208

1.25

0.47

1.3

1.4

1.21

1.46

nmol/l

0.84

192

Lichen planus, including avohilmo

559

1.15

0.47

1.2

1.3

1.50

nmol/l

0.01

506

Malignant neoplasm of corpus uteri

191

1.26

0.46

1.3

1.93

1.47

nmol/l

1.12

169

Use of anticholinesterases

659

1.12

0.46

1.2

1.11

1.47

nmol/l

4.23

594

N06DA Anticholinesterases

659

1.12

0.46

1.2

1.11

1.47

nmol/l

4.23

594

Congenital malformations of ovaries, fallopian tubes and broad ligaments

118

0.68

0.45

1.1

1.5

1.70

1.46

nmol/l

—

107

Allergic purpura

0.59

0.45

1.2

1.4

1.44

nmol/l

—

Lichen planus

375

1.17

0.45

1.3

1.39

1.47

nmol/l

0.21

339

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

123

881

0.91

0.44

1.5

1.3

1.54

1.49

nmol/l

0.21

110

792

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

123

881

0.91

0.44

1.5

1.3

1.54

1.49

nmol/l

0.21

110

792

Colonic or urogenital fistula

105

951

1.10

0.44

1.3

1.50

1.46

nmol/l

0.16

852

Benign neoplasm of middle ear and respiratory system

253

0.79

0.44

1.1

1.3

1.27

1.42

nmol/l

0.66

227

Autism

1.38

0.44

1.1

1.4

1.77

1.17

nmol/l

—

Postmenopausal atrophic vaginitis

451

1.12

0.44

1.1

1.3

1.48

1.39

nmol/l

0.37

406

Labour and delivery complicated by fetal stress [distress]

375

1.14

0.43

1.3

1.5

1.62

1.54

nmol/l

0.20

336

Inflammation of lacrimal passages (chronic)

1.57

0.42

1.2

1.0

1.36

1.49

nmol/l

—

Benign neoplasm: Skin of scalp and neck

1.41

0.42

1.5

1.1

1.29

1.40

nmol/l

—

Use of ropinirole

0.63

0.42

1.0

1.2

2.20

1.49

nmol/l

—

Varicose veins

247

1755

1.06

0.42

1.3

1.58

1.41

nmol/l

1.52

220

1584

Muscle wasting and atrophy, not elsewhere classified

0.00

0.41

0.0

1.0

—

1.49

—

Other fall from one level to another

753

0.89

0.41

1.3

1.31

1.45

nmol/l

0.58

678

Benign neoplasm: Skin of scalp and neck

1.36

0.41

1.5

1.2

1.29

1.44

nmol/l

—

Carcinoma in situ of breast, intraductal

204

1.23

0.40

1.2

1.4

1.63

1.42

nmol/l

0.47

187

Contusion of toe(s) with damage to nail

1.48

0.40

1.4

1.1

0.90

1.44

nmol/l

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

171

1264

0.93

0.40

1.3

1.40

1.44

nmol/l

0.19

153

1146

Alzheimer’s disease (Late onset)

408

0.86

0.40

1.1

1.2

1.00

1.44

nmol/l

3.14

363

Lung diseases due to external agents

399

1.15

0.39

1.5

1.3

1.37

1.45

nmol/l

0.21

355

UC patients in KELA-register (code 208), prior to 1994

133

1.28

0.38

1.2

1.4

1.63

1.50

nmol/l

0.16

121

Other and unspecified diseases of blood and blood-forming organs

1.35

0.38

1.3

1.1

1.19

1.54

nmol/l

—

Carcinoma in situ of other and unspecified sites

1.35

0.38

1.3

1.2

1.22

1.53

nmol/l

0.64

Injury of other and unspecified intrathoracic organs

188

1.23

0.37

1.1

1.2

1.25

1.40

nmol/l

0.36

170

Juvenile arthritis (FINNGEN)

1.33

0.37

1.8

1.3

1.20

1.53

nmol/l

0.51

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

114

0.70

0.37

1.5

1.2

1.95

1.45

nmol/l

—

Disturbances of smell and taste

114

0.70

0.37

1.0

1.4

1.41

1.44

nmol/l

—

100

Focal epilepsy, strict definition

600

1.12

0.37

1.5

1.3

1.54

1.48

nmol/l

0.16

539

Meningitis

134

1.27

0.37

1.3

1.4

1.19

1.46

nmol/l

0.74

120

Benign neoplasm of thyroid gland

1.34

0.36

1.2

1.4

1.36

1.28

nmol/l

0.08

Postprocedural disorders of nervous system

180

1.22

0.36

1.6

1.5

1.35

1.47

nmol/l

0.23

165

Malignant neoplasm of skin

211

1684

0.94

0.36

1.3

1.40

1.43

nmol/l

0.21

188

1525

Tooth agenesis EXCLUDE clefts and syndromes

0.65

0.35

1.0

1.5

1.37

nmol/l

—

Benign neoplasm: Tongue

0.64

0.35

1.2

1.16

1.43

nmol/l

—

Sulfasalazine

106

975

1.09

0.35

1.4

1.3

1.44

1.42

nmol/l

0.07

861

therapeutic use

0.62

0.35

1.2

1.63

1.43

nmol/l

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

537

1.12

0.34

1.1

1.3

1.38

1.45

nmol/l

0.21

480

Acute epiglottitis

1.34

0.34

1.3

1.1

1.52

1.43

nmol/l

—

Oral leukoplakia

1.34

0.34

1.0

1.1

1.42

1.56

nmol/l

—

Benign neoplasm of thyroid gland

1.32

0.34

1.2

1.5

1.36

1.31

nmol/l

0.05

Colorectal cancer, excluding all cancers (controls excluding all cancers)

878

0.91

0.33

1.3

1.36

1.43

nmol/l

0.24

795

Cerebral aneurysm, nonruptured

265

1.17

0.33

1.6

1.4

1.35

1.46

nmol/l

0.24

240

Coxarthrosis, primary

229

1886

1.05

0.32

1.3

1.63

1.42

nmol/l

2.08

202

1715

Erythema nodosum

1.35

0.32

1.4

1.3

1.93

1.52

nmol/l

—

6-mercaptopurine

1.35

0.32

1.3

0.97

1.28

nmol/l

—

Dementia

132

849

1.07

0.32

1.2

1.15

1.46

nmol/l

3.78

120

761

Purpura and other haemorrhagic conditions

407

1.13

0.32

1.3

1.64

1.51

nmol/l

0.30

367

Any dementia

749

0.92

0.32

1.1

1.2

1.09

1.48

nmol/l

3.85

676

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

209

0.81

0.32

1.2

1.4

1.38

1.46

nmol/l

0.13

190

Intermittent heterotropia

143

0.77

0.32

1.2

1.4

1.80

1.40

nmol/l

0.90

130

Papillary adenocarcinoma of thyroid gland

143

0.77

0.32

1.2

1.4

1.48

1.40

nmol/l

0.09

128

Carcinoma in situ, bladder

1.31

0.32

1.3

1.2

1.22

1.53

nmol/l

0.63

Osteonecrosis

174

1.21

0.31

1.6

1.2

1.68

1.46

nmol/l

0.32

153

Assault by sharp object

1.35

0.31

1.4

1.2

0.76

1.35

nmol/l

—

Rheumatic valve diseases

1.35

0.31

1.3

1.1

1.15

1.61

nmol/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1059

0.92

0.31

1.3

1.53

1.45

nmol/l

0.29

949

severe traumatic brain injury, does not include concussion

695

1.09

0.30

1.4

1.2

1.37

1.46

nmol/l

0.28

625

Alzheimer disease, excluding more controls

291

1.12

0.30

1.2

1.07

1.42

nmol/l

2.46

262

Autoimmune hyperthyroidism

120

1.25

0.30

1.1

1.5

1.71

1.57

nmol/l

—

112

Impetigo

102

1.28

0.30

1.2

1.4

1.01

1.46

nmol/l

1.73

Malignant neoplasm of thyroid gland

196

0.82

0.30

1.2

1.3

1.43

1.51

nmol/l

0.13

173

Triptan medication for migraine, single purchase ok

298

2105

0.96

0.29

1.4

1.3

1.55

1.46

nmol/l

0.76

272

1894

Migraine, single triptan purchase ok & required. ICD-code if available is included

298

2105

0.96

0.29

1.4

1.3

1.55

1.46

nmol/l

0.76

272

1894

Malignant neoplasm of breast, HER-negative

535

0.90

0.29

1.5

1.3

1.59

1.39

nmol/l

0.54

486

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

477

1.11

0.29

1.3

1.32

1.49

nmol/l

0.64

430

Colectomy operation

525

1.11

0.29

1.2

1.3

1.21

1.48

nmol/l

1.28

464

Contact with heat and hot substances

139

1.22

0.29

1.4

1.5

1.24

1.37

nmol/l

0.33

127

Other and unspecified types of non-Hodgkin lymphoma, hilmo

109

0.73

0.29

1.5

1.2

1.95

1.51

nmol/l

—

Other abnormal products of conception

586

1.08

0.28

1.4

1.34

1.56

nmol/l

1.09

528

Pedestrian injured in collision with car, pick-up truck or van

1.29

0.28

1.3

1.1

1.17

1.45

nmol/l

—

LSIL lesion of the vulva

1.29

0.28

2.1

1.5

1.38

1.39

nmol/l

—

Obstructed labour due to malposition and malpresentation of fetus

551

1.09

0.27

1.6

1.5

1.48

1.47

nmol/l

0.01

497

Pedal cyclist injured in transport accident

721

1.08

0.26

1.2

1.3

1.40

1.45

nmol/l

0.15

647

COPD, hospital admissions 3, with asthma pneumonia sepsis

736

1.07

0.26

1.5

1.2

1.68

1.43

nmol/l

1.16

659

Benign neoplasm: Tongue

0.69

0.26

1.2

1.16

1.45

nmol/l

—

COPD, hospital admissions 1, only main diagnosis

110

999

0.94

0.26

1.4

1.2

1.53

1.44

nmol/l

0.34

899

Speech therapy

894

0.93

0.26

1.2

1.3

1.12

1.48

nmol/l

3.18

800

Delivery

132

657

1.06

0.26

1.4

1.3

1.57

1.48

nmol/l

0.42

121

581

Congenital malformations of genital organs

212

0.84

0.25

1.3

1.4

1.64

1.46

nmol/l

0.31

189

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

598

0.92

0.25

1.4

1.3

1.50

1.45

nmol/l

0.12

535

Chronic diseases of tonsils and adenoids

350

2140

1.04

0.24

1.4

1.3

1.47

1.43

nmol/l

0.27

318

1938

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

1.19

0.24

1.6

1.2

1.46

1.55

nmol/l

—

Hyperplasia of prostate

179

972

1.05

0.24

1.2

1.3

1.38

1.40

nmol/l

0.12

155

887

Temporomandibular joint disorders, including avohilmo

130

1372

0.95

0.24

1.5

1.4

1.61

1.45

nmol/l

0.84

120

1235

Presence of other devices

647

1.08

0.24

1.2

1.48

1.42

nmol/l

0.23

577

Other and unspecified intracranial injuries

0.73

0.24

1.7

1.2

1.75

1.32

nmol/l

—

Contact with other hot fluids

0.70

0.24

1.3

1.16

1.32

nmol/l

—

Malignant melanoma

465

1.10

0.24

1.1

1.3

1.30

1.51

nmol/l

0.93

419

Antenatal screening

364

1.08

0.23

1.4

1.58

1.46

nmol/l

0.45

323

Monoarthritis, not elsewhere classified

115

1.22

0.23

1.1

1.2

2.05

1.58

nmol/l

0.69

107

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.32

0.23

1.2

1.21

1.44

nmol/l

—

Assault by blunt object

1.32

0.23

1.6

1.1

0.92

1.41

nmol/l

—

Left ventricular outflow tract obstruction, narrow definition

143

1.19

0.23

1.1

1.3

1.79

1.42

nmol/l

0.63

125

Certolizumab pegol

1.28

0.23

1.2

1.3

1.44

1.49

nmol/l

—

Carcinoma in situ of other and unspecified sites

1.24

0.23

1.3

1.2

1.22

1.51

nmol/l

0.59

Benign neoplasm: Larynx

1.25

0.22

1.0

1.2

1.24

1.54

nmol/l

0.89

Melanocytic naevi

100

941

1.06

0.22

1.6

1.3

1.32

1.47

nmol/l

0.70

843

Dental caries 2 and operation codes

311

2389

1.03

0.22

1.5

1.3

1.30

1.45

nmol/l

1.79

277

2164

Other sexually transmitted chlamydial diseases

146

0.82

0.22

2.2

1.4

0.63

1.44

nmol/l

3.19

133

Malignant neoplasm of endocrine gland

210

0.86

0.22

1.2

1.3

1.45

1.52

nmol/l

0.11

187

Brain meningioma

135

0.81

0.22

1.0

1.4

0.97

1.45

nmol/l

1.11

117

Sequelae of injuries of head

163

1.17

0.21

1.5

1.4

0.91

1.48

nmol/l

1.53

150

Benign neoplasm: Other/unspecified site

1.19

0.21

1.0

1.2

1.90

1.53

nmol/l

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

135

1.19

0.21

1.7

1.2

1.73

1.49

nmol/l

0.56

117

Polyp of the female genital tract

102

559

1.06

0.21

1.4

1.3

1.63

1.37

nmol/l

1.35

498

Hypersensitivity pneumonitis due to organic dust

1.16

0.21

1.6

1.1

0.97

1.65

nmol/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.16

0.21

1.4

1.1

0.77

1.28

nmol/l

—

Contact with and exposure to communicable diseases

103

970

1.06

0.20

1.7

1.4

1.43

1.41

nmol/l

0.07

872

Muscle strain

1.25

0.20

1.4

1.2

1.19

1.34

nmol/l

—

Other acquired deformities of ankle and foot

0.00

0.20

0.0

1.0

—

1.43

—

Epiphora

1.23

0.20

1.3

1.2

1.54

1.49

nmol/l

—

Female infertility, tubal origin

111

0.81

0.20

1.3

1.2

1.58

1.37

nmol/l

—

Thyrotoxicosis with diffuse goitre

355

1.10

0.20

1.2

1.4

1.38

1.47

nmol/l

0.15

320

Nasal polyp

674

1.07

0.20

1.4

1.3

1.33

1.47

nmol/l

0.57

610

Other and unspecified hydrocephalus

1.20

0.19

1.2

1.1

1.67

1.55

nmol/l

—

Benign mammary dysplasia

354

0.90

0.19

1.4

1.55

1.45

nmol/l

0.21

318

Ill-defined and unknown causes of mortality

175

0.86

0.18

1.1

1.2

1.68

1.50

nmol/l

0.19

155

Perioral dermatitis

1.13

0.18

2.2

1.5

1.53

1.55

nmol/l

—

In situ neoplasms

116

1106

1.05

0.18

1.2

1.3

1.45

1.47

nmol/l

0.08

105

993

Unspecified haematuria

161

1325

1.04

0.18

1.2

1.3

1.47

1.40

nmol/l

0.33

139

1198

Basal cell carcinoma

185

1528

0.96

0.17

1.3

1.40

1.43

nmol/l

0.15

166

1383

Nontraumatic intracranial haemmorrhage

590

1.07

0.17

1.4

1.3

1.34

1.44

nmol/l

0.40

527

Paraplegia, diplegia of upper limbs

1.13

0.17

1.1

1.15

1.60

nmol/l

—

Benign neoplasm: Rectosigmoid junction

110

1.18

0.17

1.2

1.32

1.36

nmol/l

0.05

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

465

1.08

0.17

1.1

1.3

1.42

1.44

nmol/l

0.05

416

Unspecified nephritic syndrome

1.11

0.17

1.3

1.2

1.79

1.51

nmol/l

—

Inguinal hernia, bilateral

382

0.92

0.17

1.3

1.2

1.14

1.46

nmol/l

1.52

335

Burn and corrosion of head and neck

0.76

0.17

1.2

1.66

1.39

nmol/l

—

Malignant neoplasm, without specification of site

0.75

0.17

1.0

1.1

1.18

1.55

nmol/l

—

Distal bite

0.74

0.17

1.8

1.3

1.58

1.26

nmol/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.18

0.16

1.5

1.3

1.47

1.52

nmol/l

—

Melanocytic naevi of trunk

340

1.09

0.16

1.3

1.19

1.46

nmol/l

0.78

307

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

207

1460

0.97

0.16

1.3

1.43

1.45

nmol/l

0.09

182

1323

Contact with sharp object, undetermined intent

1.14

0.16

1.5

1.2

1.16

1.44

nmol/l

—

Injuries to the elbow and forearm

264

2320

1.03

0.16

1.4

1.3

1.38

1.44

nmol/l

0.39

237

2095

Voice disturbances

833

0.95

0.16

1.7

1.3

1.66

1.48

nmol/l

0.69

740

Other inflammation of vagina/vulva

1.13

0.16

1.0

1.6

1.47

1.52

nmol/l

—

Benign neoplasm: Larynx

1.20

0.16

1.0

1.2

1.24

1.41

nmol/l

0.41

Acute nasopharyngitis (common cold)

435

1.07

0.16

1.4

1.3

1.22

1.43

nmol/l

0.72

399

Deep endometriosis

235

0.89

0.16

1.3

1.4

1.42

1.56

nmol/l

0.39

210

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.09

0.15

1.3

1.34

1.25

nmol/l

—

Abnormalities of forces of labour

235

1.11

0.15

1.3

1.5

1.71

1.46

nmol/l

0.46

211

Carcinoma in situ of skin of trunk

0.78

0.15

1.2

1.44

1.55

nmol/l

—

Other congenital malformations of face and neck

0.75

0.15

1.2

1.5

1.42

1.27

nmol/l

—

TMD related pain

1.21

0.15

1.7

1.5

1.72

1.39

nmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

1.14

0.15

1.3

1.1

2.58

1.54

nmol/l

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

140

0.86

0.15

1.0

1.4

0.97

1.50

nmol/l

1.44

124

Endometriosis of rectovaginal septum and vagina

182

0.88

0.15

1.4

1.3

1.51

1.38

nmol/l

0.31

161

In situ neoplasms

116

1064

1.04

0.14

1.2

1.3

1.45

1.48

nmol/l

0.12

105

959

Melanocytic naevi

100

960

1.04

0.13

1.6

1.3

1.32

1.43

nmol/l

0.47

857

Ankylosing spondylitis, strict definition

138

0.87

0.13

1.1

1.4

1.53

1.41

nmol/l

0.17

128

Non-follicular lymphoma

304

0.92

0.13

1.3

1.32

1.50

nmol/l

0.53

271

Carcinoma in situ of cervix uteri

190

1.11

0.12

1.5

1.6

1.64

1.50

nmol/l

0.34

169

Convalescence

142

1.13

0.12

1.5

1.4

1.26

1.48

nmol/l

0.44

125

Unspecific neurodegenerative disorder

117

778

1.04

0.12

1.2

1.13

1.47

nmol/l

4.84

108

701

Embedded and impacted teeth

609

1.05

0.12

1.3

1.4

1.43

1.41

nmol/l

0.07

552

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

231

0.91

0.12

1.1

1.4

1.42

1.45

nmol/l

0.05

209

Non-follicular lymphoma, hilmo, excluding all cancers

303

0.92

0.12

1.3

1.32

1.47

nmol/l

0.43

270

Separation of retinal layers (serosa)

116

0.86

0.12

1.3

1.2

1.72

1.51

nmol/l

—

108

Osteoporosis

678

0.96

0.11

1.3

1.53

1.42

nmol/l

0.34

617

Atypical facial pain

126

0.87

0.11

1.3

1.2

1.28

1.38

nmol/l

0.15

112

Basal cell carcinoma, including avohilmo

193

1557

0.98

0.11

1.3

1.41

1.43

nmol/l

0.09

173

1410

Malignant melanoma of skin

357

1.06

0.11

1.1

1.3

1.34

1.48

nmol/l

0.41

320

Bicuspidal aortic valve syndrome

115

0.87

0.10

1.1

1.2

1.65

1.40

nmol/l

—

Bacterial meningitis

1.15

0.10

1.3

1.4

1.14

1.44

nmol/l

0.52

Fenamates

354

1.05

0.09

1.3

1.2

1.71

1.40

nmol/l

1.11

319

Glucosamine medication

171

1333

1.02

0.09

1.3

1.57

1.45

nmol/l

0.86

154

1204

Congenital malformations of great arteries

1.07

0.09

1.0

1.3

2.02

1.16

nmol/l

—

Foreign body on external eye

546

1.04

0.09

1.5

1.3

1.49

1.45

nmol/l

0.12

493

Laparoscopic left hemicolectomy

1.04

0.09

1.4

1.1

0.85

1.73

nmol/l

—

Other and unspecified iridocyclitis

116

1.12

0.09

1.4

1.69

1.43

nmol/l

0.34

104

Endometriosis ASRM stages 3,4

625

0.96

0.09

1.3

1.4

1.62

1.49

nmol/l

0.36

561

Endometriosis of ovary

447

1.05

0.09

1.3

1.4

1.68

1.36

nmol/l

0.92

394

Fracture at wrist and hand level

127

1237

1.03

0.09

1.3

1.34

1.42

nmol/l

0.37

112

1110

Postprocedural musculoskeletal disorders, not elsewhere classified

194

1.08

0.09

1.3

1.37

1.53

nmol/l

0.29

172

Allergic contact dermatitis due to drugs in contact with skin

1.09

0.09

1.2

1.28

1.44

nmol/l

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

1.07

0.08

1.7

1.1

1.95

1.60

nmol/l

—

Contact with sharp glass

113

0.88

0.08

1.1

1.3

1.03

1.38

nmol/l

—

103

Benign neoplasm of male genital organs

0.82

0.08

1.0

1.2

2.00

1.49

nmol/l

—

Crushed, pushed or stepped on by crowd or human stampede

185

0.92

0.08

1.2

1.4

1.10

1.40

nmol/l

0.55

171

Correction of physiology of bite - demanding therapy visit

185

1.08

0.08

1.4

1.78

1.45

nmol/l

0.64

169

Benign neoplasm of male genital organs

0.77

0.08

1.0

1.2

2.00

1.50

nmol/l

—

Benign neoplasm: Rectosigmoid junction

117

1.11

0.08

1.2

1.3

1.32

1.42

nmol/l

0.12

Erosion and ectropion of cervix uteri

1.08

0.08

1.4

1.2

1.85

1.59

nmol/l

—

Outcome of delivery

260

0.95

0.08

1.4

1.5

1.48

nmol/l

0.01

228

Injury of eye and orbit

490

1.04

0.07

1.4

1.3

1.55

1.40

nmol/l

0.27

441

Burn and corrosion confined to eye and adnexa

0.80

0.07

1.2

1.5

1.69

1.31

nmol/l

—

Benign lipomatous neoplasm

104

1014

1.03

0.07

1.2

1.3

1.62

1.41

nmol/l

1.23

911

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

1.08

0.07

1.1

1.2

1.23

1.41

nmol/l

—

Rare circulating lymphoid malignancy

1.07

0.07

1.1

1.2

1.23

1.60

nmol/l

—

Acute posthaemorrhagic anaemia

1.05

0.07

1.1

2.39

1.56

nmol/l

—

Fracture of femur

673

1.03

0.07

1.3

1.39

1.44

nmol/l

0.15

599

Any dementia, excluding more controls

670

0.97

0.07

1.1

1.2

1.07

1.43

nmol/l

3.36

598

Burn and corrosion of wrist and hand

108

1.11

0.07

1.3

1.21

1.44

nmol/l

0.42

Injury of muscle and tendon at wrist and hand level

471

1.04

0.07

1.2

1.3

1.45

1.46

nmol/l

0.03

421

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

153

0.91

0.07

1.4

1.14

1.41

nmol/l

—

133

Dental caries 2, only avohilmo

298

2381

0.99

0.07

1.6

1.3

1.31

1.45

nmol/l

1.63

266

2158

Other ill-defined and unspecified causes of mortality

153

0.91

0.07

1.1

1.2

1.72

1.48

nmol/l

0.23

134

Cardiodefibrillation

128

1305

0.98

0.07

1.2

1.3

1.60

1.41

nmol/l

1.12

116

1177

Burns and corrosions confined to eye and internal organs

1.07

0.07

1.6

1.5

1.54

1.37

nmol/l

—

Dental caries 2

313

2428

1.01

0.07

1.5

1.3

1.30

1.45

nmol/l

1.75

279

2200

Later onset COPD, excluding more controls

506

1.03

0.07

1.1

1.2

1.74

1.38

nmol/l

1.32

457

Follow-up care involving plastic surgery

0.85

0.06

1.6

1.5

1.47

1.43

nmol/l

—

Other vitreous opacities

101

0.89

0.06

2.0

1.2

1.92

1.46

nmol/l

—

All dysplastic lesions of the vulva

102

0.88

0.06

2.0

1.4

1.51

1.40

nmol/l

—

Inguinal or femoral hernia, bilateral

386

0.96

0.06

1.3

1.2

1.16

1.46

nmol/l

1.37

339

Other predominantly sexually transmitted diseases, not elsewhere classified

477

0.96

0.06

1.4

1.29

1.43

nmol/l

0.59

432

Ethmoidectomy

414

1.04

0.06

1.9

1.3

1.53

1.43

nmol/l

0.22

374

Triptan medication for migraine, min. 3 purchases

190

1521

0.99

0.06

1.4

1.48

1.47

nmol/l

0.04

177

1373

Special screening examination for infectious and parasitic diseases

560

0.97

0.05

1.3

1.4

1.28

1.44

nmol/l

0.57

506

Impacted teeth

441

1.03

0.05

1.3

1.4

1.47

1.39

nmol/l

0.21

404

Vertical strabismus

1.11

0.05

1.2

1.4

1.99

1.41

nmol/l

—

Any event in cancer register

415

2483

0.99

0.05

1.4

1.3

1.47

1.44

nmol/l

0.20

372

2245

Colorectal adenocarcinoma

617

0.97

0.05

1.3

1.2

1.24

1.48

nmol/l

1.39

546

Benign lipomatous neoplasm

104

1020

1.02

0.05

1.2

1.3

1.62

1.45

nmol/l

0.90

911

Prepatellar bursitis

149

1.07

0.05

1.3

1.35

1.41

nmol/l

0.08

135

Nontoxic goitre/thyroid nodule

902

1.02

0.05

1.4

1.3

1.34

1.47

nmol/l

0.61

811

Melanocytic naevi of lower limb, including hip

120

0.92

0.05

1.7

1.4

1.51

1.45

nmol/l

0.05

103

Disorders of refraction and accommodation

810

1.02

0.04

1.3

1.4

1.43

1.44

nmol/l

0.05

727

Melanocytic naevi of trunk

357

1.04

0.04

1.3

1.19

1.48

nmol/l

0.87

318

Carcinoma in situ of cervix uteri

199

1.06

0.04

1.5

1.64

1.48

nmol/l

0.38

178

Secondary uncertain malignant neoplasm

397

1.03

0.04

1.3

1.22

1.52

nmol/l

1.33

354

L01XE Protein kinase inhibitors

160

1.06

0.04

1.4

1.3

1.06

1.43

nmol/l

0.85

140

Coxarthrosis, primary, with hip surgery

160

1500

1.01

0.03

1.2

1.3

1.62

1.41

nmol/l

1.64

140

1364

Fracture of forearm

189

1785

0.99

0.03

1.4

1.3

1.34

1.45

nmol/l

0.77

169

1609

Intracerebral haemorrhage

330

1.03

0.03

1.3

1.2

1.53

1.44

nmol/l

0.23

296

Asthma and opportunity respiratory infection

112

1.07

0.03

1.1

1.2

2.06

1.47

nmol/l

0.77

100

FESS (DNB20)

400

1.03

0.02

2.0

1.3

1.44

1.42

nmol/l

0.04

364

Colorectal cancer

711

0.98

0.02

1.3

1.2

1.30

1.47

nmol/l

0.78

630

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

610

0.98

0.02

1.3

1.24

1.46

nmol/l

1.25

550

Vestibular neuronitis

282

1.03

0.02

1.1

1.3

1.38

1.44

nmol/l

0.11

257

Symptoms and signs involving speech and voice

106

1050

1.01

0.01

1.5

1.3

1.62

1.46

nmol/l

0.63

935

Abnormal findings in secretions and smears from cervix uteri vagina vulva

151

1178

1.01

0.01

1.4

1.45

1.50

nmol/l

0.24

138

1068

Congenital malformations of eye, ear, face and neck

163

1.04

0.01

1.1

1.4

1.47

nmol/l

0.01

148

Single spontaneous delivery

122

654

0.99

0.01

1.3

1.55

1.48

nmol/l

0.26

111

578

Striking against or struck by other objects

116

1152

1.01

0.01

1.5

1.3

1.57

1.43

nmol/l

0.67

105

1040

Melanocytic naevi of lower limb, including hip

116

0.95

0.00

1.7

1.4

1.51

1.43

nmol/l

0.07

103

Foreign body entering into or through eye or natural orifice

246

0.98

0.00

1.2

1.3

1.39

nmol/l

0.01

223

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

776

0.99

0.00

1.3

1.44

nmol/l

0.01

700

Female genital prolapse

517

1.00

0.00

1.3

1.57

1.36

nmol/l

1.05

463

Graves disease, strict definition

258

1.01

0.00

1.2

1.4

1.20

1.46

nmol/l

0.75

234

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

115

0.96

0.00

1.2

1.53

1.45

nmol/l

0.09

100

Use of other anti-dementia drugs

510

1.01

0.00

1.2

1.09

1.46

nmol/l

3.27

457

Use of memantine

510

1.01

0.00

1.2

1.09

1.46

nmol/l

3.27

457

Other disorders of veins

131

1313

1.00

0.00

1.4

1.3

1.53

1.43

nmol/l

0.46

120

1179

Other specified and unspecified disorders of eye and adnexa

102

0.98

0.00

1.1

1.3

1.82

1.36

nmol/l

—

Other specified disorders of external ear

102

0.98

0.00

1.3

1.2

1.08

1.51

nmol/l

—

Additional codes for the location of defect, injury or illness

152

0.99

0.00

1.3

1.4

1.82

1.39

nmol/l

0.83

134

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

423

0.99

0.00

1.3

1.35

1.47

nmol/l

0.37

383

Myocardial infarction, with ST-elevation

563

0.99

0.00

1.3

1.2

1.18

1.47

nmol/l

1.82

498

Acute appendicitis, with complications

688

1.00

0.00

1.4

1.3

1.67

1.46

nmol/l

0.58

619

Presbycusis

323

1.02

0.00

1.2

1.58

1.44

nmol/l

0.27

285

Congenital malformations of aortic and mitral valves

127

1.02

0.00

1.1

1.3

1.68

1.38

nmol/l

0.42

110

Pleural plaque

277

1.01

0.00

1.5

1.2

1.40

1.48

nmol/l

0.19

243

Alzheimer disease, including avohilmo

637

1.00

0.00

1.1

1.2

1.08

1.49

nmol/l

5.05

575

Eclampsia

0.00

0.0

1.0

—

1.28

—

Crushing injury of head

0.00

0.0

1.2

—

1.71

—

Melanocytic naevi of scalp and neck

0.91

0.00

3.2

1.2

0.96

1.40

nmol/l

—

Alpha thalassaemia

0.00

0.0

1.2

—

1.72

—

Protozoal diseases

0.99

0.00

1.1

1.2

1.28

1.44

nmol/l

—

Other infections specific to the perinatal period

0.00

0.0

1.2

—

1.42

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.0

1.2

—

1.01

—

Carcinoma in situ of larynx

0.00

0.0

1.2

—

2.29

—

Abnormal pulmonary venous return

0.00

0.0

1.3

—

1.58

—

Folliculitis decalvans

0.00

0.0

1.2

—

1.82

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.2

—

2.06

—

Kissing spine

0.00

0.0

1.0

—

1.10

—

Melanocytic naevi of scalp and neck

0.86

0.00

3.2

1.2

0.96

1.37

nmol/l

—

0.91

0.00

1.2

1.1

1.29

1.50

nmol/l

—

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

1.48

—

Inguinal hernia, unilateral

1.00

0.00

1.1

1.2

1.56

1.51

nmol/l

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.0

1.3

—

1.95

—

Golimumab

0.96

0.00

2.4

1.4

1.91

1.42

nmol/l

—

Hypoparathyroidism

0.92

0.00

1.2

1.69

1.36

nmol/l

—

Carcinoma in situ of skin of scalp and neck

0.89

0.00

1.0

1.2

0.65

1.51

nmol/l

—

Erythrasma

0.00

0.0

1.2

—

1.61

—

Palatinal maxillary operation

0.00

0.0

1.0

—

1.08

—

Palatinal maxillary canine

0.00

0.0

1.0

—

1.24

—

Use of trihexyphenidyl

0.00

0.0

1.0

—

2.35

—

Acquired atrophy of ovary and fallopian tube

0.00

0.0

1.0

—

1.85

—

Malignant neoplasm of other and unspecified urinary organs

0.00

0.0

1.0

—

1.53

—

Procedures for purposes other than remedying health state

0.92

0.00

1.0

1.6

1.39

1.31

nmol/l

—

Other congenital malformations of skull and face bones

0.00

0.0

1.2

—

1.15

—

Carcinoma in situ of skin of lip

0.00

0.0

1.1

—

2.06

—

Carcinoma in situ of skin of trunk

1.00

0.00

1.2

1.1

1.44

1.56

nmol/l

—

Carcinoma in situ of skin of scalp and neck

1.02

0.00

1.0

1.1

0.65

1.54

nmol/l

—

Carcinoma in situ of larynx

0.00

0.0

1.2

—

2.46

—

Other disorders of binocular movement

0.86

0.00

1.2

1.3

1.32

1.43

nmol/l

—

Injury of muscle and tendon at forearm level

1.02

0.00

1.5

1.1

2.13

1.42

nmol/l

—

Injury of muscle and tendon at ankle and foot level

0.88

0.00

1.2

1.3

3.34

1.44

nmol/l

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.0

1.0

—

1.10

—

Nonadministration of surgical and medical care

0.00

0.0

1.0

—

1.99

—

Abscess of mediastinum

0.00

0.0

1.2

—

1.16

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

0.0

1.0

—

1.50

—

Patellar tendinitis

0.94

0.00

1.0

1.4

1.36

1.11

nmol/l

—

Moyamoya

0.00

0.0

1.2

—

1.88

—

Femoral hernia, unilateral

1.00

0.00

1.1

1.2

1.56

1.51

nmol/l

—

Viral agents as the cause of diseases classified to other chapters

0.98

0.00

1.2

0.93

1.34

nmol/l

—

Inguinal of femoral hernia, unilateral

1.00

0.00

1.1

1.2

1.56

1.51

nmol/l

—

Other obstetric trauma

0.95

0.00

1.3

1.5

1.39

1.54

nmol/l

—

Dislocation, sprain and strain of joint and ligaments of hip

0.92

0.00

2.1

1.2

1.84

1.48

nmol/l

—

Complications specific to multiple gestation

0.00

0.0

1.2

—

1.54

—

Anomalies of pupillary function

0.98

0.00

1.2

2.02

1.40

nmol/l

—

Correction of physiology of bite - very demanding therapy visit

0.99

0.00

1.1

1.6

1.18

1.45

nmol/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

C peptide [Moles/volume] in Serum or Plasma --post meal

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS